Suggestive for eosinophilic asthma

ASTHMA_EOSINOPHIL_SUGG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions J10_ASTHMA	70209
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints J10_NASALPOLYP M13_CHURGSTRAUSS J10_PULMEOS Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT	4319
6. Filter based on genotype QC (FinnGen only)	3901

Control definitions (FinnGen only)

Control conditions: not J10_ASTHMA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_EOSINOPHIL_SUGG
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!J10_ASTHMA
SEX
INCLUDE	J10_NASALPOLYP\|M13_CHURGSTRAUSS\|J10_PULMEOS\|Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT
PRE_CONDITIONS
CONDITIONS	J10_ASTHMA
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Suggestive for eosinophilic asthma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	21151	9574	11468
Only index persons	19226	8895	10331
Unadjusted period prevalence (%)
Whole population	0.30	0.27	0.32
Only index persons	0.36	0.33	0.39
Median age at first event (years)
Whole population	51.33	50.38	52.09
Only index persons	50.40	49.51	51.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3901	1935	1966
Unadjusted period prevalence (%)	0.80	0.69	0.90
Median age at first event (years)	50.67	48.57	52.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4021: Matched controls
40210

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

3.7

320.2

2799

15445

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

40.5

317.4

193

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

7.7

316.3

472

681

R06AX27

ATC

desloratadine; oral

3.5

311.8

1675

6837

J32.4

ICD-10 Finland

Chronic pansinusitis

84.3

307.7

884

134

J33.8

ICD-10 Finland

Other polyp of sinus

155.7

307.7

1832

215

R03BA08

ATC

ciclesonide; inhalant

10.9

307.7

911

1056

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

38.4

307.7

279

H02AB07

ATC

prednisone; oral

7.2

307.7

1319

2552

R01AD08

ATC

fluticasone; nasal

21.2

307.7

3278

6919

R01AD05

ATC

budesonide; nasal

11.8

307.7

1084

1220

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

17.4

307.7

290

179

J46

ICD-10 Finland

Status asthmaticus

149.3

307.7

554

J33

ICD-10 Finland

Nasal polyp

35.5

307.7

281

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

101.4

307.7

184

R03AC03

ATC

terbutaline; inhalant

9.5

307.7

1323

1972

UDH02

NOMESCO Finland

Rhinopharyngoscopy

17.5

307.7

1377

1163

TDM10

NOMESCO Finland

Puncture of maxillary antrum

25.1

307.7

973

504

R03DA04

ATC

theophylline; systemic, rectal

19.0

307.7

648

402

D11AH05

ATC

dupilumab; topical

120.5

307.7

184

J45.9

ICD-10 Finland

Asthma, unspecified

183.5

307.7

3339

1045

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

16.4

307.7

823

620

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

58.7

307.7

383

H02AB04

ATC

methylprednisolone; systemic

8.3

307.7

1519

2735

R01AD12

ATC

fluticasone furoate; nasal

4.1

307.7

2004

7845

R06AE07

ATC

cetirizine; oral

3.6

307.7

2394

11652

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

64.0

307.7

1361

319

R01AD58

ATC

fluticasone, combinations; nasal

4.3

307.7

1702

5904

R96

ICPC

Asthma

23.5

307.7

1398

892

R03AK08

ATC

formoterol and beclometasone; inhalant

30.7

307.7

684

267

49300

ICD-8 Finland

Asthma, bronchiale

+∞

307.7

515

J33.0

ICD-10 Finland

Polyp of nasal cavity

172.2

307.7

2487

375

R03DC01

ATC

zafirlukast; oral

39.2

307.7

254

UDM02

NOMESCO Finland

Sinoscopy

18.6

307.7

524

321

J31.0

ICD-10 Finland

Chronic rhinitis

5.6

307.7

773

1631

R03BA02

ATC

budesonide; inhalant

15.1

307.7

2050

2592

4222

FHL

Endonasal etmoidectomy

76.5

307.7

356

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

14.7

307.7

494

380

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

19.0

307.7

425

249

XG474

NOMESCO Finland

Exhalation nntrogen oxide

24.7

307.7

317

139

ZXA10

NOMESCO Finland

Bilateral

4.6

307.7

1425

4259

R03BA01

ATC

beclometasone; inhalant

12.9

307.7

1545

1849

395

Kela drug reimbursment

Dupilumab

129.1

307.7

173

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

42.0

307.7

1846

797

H02AB06

ATC

prednisolone; systemic

21.6

307.7

3654

12670

J33.9

ICD-10 Finland

Nasal polyp, unspecified

47.3

307.7

612

152

R03AK07

ATC

formoterol and budesonide; inhalant

8.8

307.7

1990

4022

J45.8

ICD-10 Finland

Mixed asthma

154.7

307.7

560

R03AK11

ATC

formoterol and fluticasone; inhalant

24.6

307.7

353

157

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

21.1

307.7

1656

1292

R01BA52

ATC

pseudoephedrine, combinations; oral

3.6

307.7

1852

7626

J45.0

ICD-10 Finland

Predominantly allergic asthma

179.5

307.7

1785

178

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

135.5

307.7

230

R01AD09

ATC

mometasone; nasal

7.6

307.7

3099

12353

J45.1

ICD-10 Finland

Nonallergic asthma

257.4

307.7

1523

R01AD01

ATC

beclometasone; nasal

6.5

307.7

1454

3219

R03AC02

ATC

salbutamol; inhalant

22.1

307.7

3716

14277

R03BA05

ATC

fluticasone; inhalant

10.6

307.7

1790

2833

DPA30

NOMESCO Finland

Sphenotomy

75.0

307.7

356

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

130.0

307.7

3376

1556

R03AK06

ATC

salmeterol and fluticasone; inhalant

15.5

307.7

1695

1808

R03BB04

ATC

tiotropium bromide; inhalant

12.5

307.7

1151

1247

J45

ICD-10 Finland

Asthma

33.7

307.7

1660

822

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

20.3

307.7

696

411

R03DC03

ATC

montelukast; oral

25.6

307.7

2381

2159

DHB20

NOMESCO Finland

Polypectomy of internal nose

112.1

307.7

1211

154

R03AC12

ATC

salmeterol; inhalant

35.3

307.7

729

251

J01.0

ICD-10 Finland

Acute maxillary sinusitis

4.7

307.7

1770

5716

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

119.0

307.7

348

XQ800

NOMESCO Finland

Prick test

6.9

307.7

618

1026

R03AC13

ATC

formoterol; inhalant

24.2

307.7

723

361

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

8.0

300.7

431

593

R01AD11

ATC

triamcinolone; nasal

5.1

290.2

701

1610

DHB50

NOMESCO Finland

Turbinoplasty

9.6

283.2

347

393

J01FA10

ATC

azithromycin; systemic

3.4

273.0

2830

16624

J01AA02

ATC

doxycycline; systemic

5.9

264.2

3675

25849

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

4.3

262.7

790

2150

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

44.7

261.5

155

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.5

259.4

1176

4242

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

105.8

258.3

133

R06AE09

ATC

levocetirizine; oral

3.9

255.9

930

2897

4224

FHL

Endonasal anthrostomy

19.6

252.7

198

106

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

251.7

239

J34.2

ICD-10 Finland

Deviated nasal septum

5.5

250.9

533

1089

J01FA06

ATC

roxithromycin; oral

3.0

250.7

2088

10670

J01FA09

ATC

clarithromycin; systemic

3.0

240.7

1697

7877

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

15.5

236.9

209

142

J30.3

ICD-10 Finland

Other allergic rhinitis

8.1

235.4

331

443

H65.3

ICD-10 Finland

Chronic mucoid otitis media

11.6

231.2

243

221

D72.1

ICD-10 Finland

Eosinophilia

48.7

227.0

132

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.5

219.6

328

470

DJD20

NOMESCO Finland

Plastic repair of septum of nose

6.2

218.4

394

688

R06AX22

ATC

ebastine; oral

3.4

216.2

1003

3625

R02

ICPC

Shortness of breath/dyspnoea

3.6

216.1

843

2729

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

551.5

213.1

210

R06AX13

ATC

loratadine; oral

3.5

213.0

878

2944

DHA10

NOMESCO Finland

Biopsy of cavity of nose

19.1

208.6

165

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.8

199.8

1411

6430

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

19.2

199.1

157

R06.2

ICD-10 Finland

Wheezing

6.8

199.0

325

512

DNB10

NOMESCO Finland

Endonasal ethmoidectomy

104.6

197.7

102

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

16.3

196.8

168

107

R06.0

ICD-10 Finland

Dyspnoea

2.8

192.9

1416

6564

XG410

NOMESCO Finland

Flow-volume spirometry

6.8

192.6

316

500

J32.8

ICD-10 Finland

Other chronic sinusitis

24.5

187.2

133

J47

ICD-10 Finland

Bronchiectasis

12.0

186.9

191

166

4226

FHL

Posterior radical surgery and possible etmoidectomy

18.7

185.6

148

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.1

184.6

578

1598

J01MA14

ATC

moxifloxacin; systemic

3.8

178.5

607

1777

J01FA15

ATC

telithromycin; oral

3.7

175.2

634

1935

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

5.4

175.1

365

727

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.1

174.7

393

837

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

173.2

165

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

170.2

1341

6372

R06AX26

ATC

fexofenadine; oral

4.4

166.9

458

1145

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

22.0

164.7

122

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

162.6

155

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.4

157.8

429

1063

DMB10

NOMESCO Finland

Radical maxillary antrotomy

22.1

154.2

114

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

152.7

2293

14416

J01.4

ICD-10 Finland

Acute pansinusitis

15.8

152.6

132

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

31.7

152.4

J01DA06

ATC

[U] cefuroxime

3.0

152.2

817

3156

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

9.4

150.2

183

204

J32.1

ICD-10 Finland

Chronic frontal sinusitis

18.8

150.0

119

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

148.9

142

C01CA24

ATC

epinephrine; parenteral

4.5

148.4

386

923

ZXC95

NOMESCO Finland

Use of surgical navigator

10.0

141.1

163

169

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

20.7

138.2

105

J01.1

ICD-10 Finland

Acute frontal sinusitis

8.5

136.9

179

218

4239

FHL

Other measure in this category

23.9

136.8

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

50.3

136.8

R03BB01

ATC

ipratropium bromide; inhalant

6.6

136.7

227

362

J01CA04

ATC

amoxicillin; systemic

3.0

128.1

3488

27522

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.6

126.8

458

1383

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

29.6

126.5

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

9.4

122.1

147

161

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

4.6

119.0

298

689

R03BC01

ATC

cromoglicic acid; inhalant

12.0

117.2

119

102

H65.2

ICD-10 Finland

Chronic serous otitis media

8.6

116.9

151

181

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

21.7

116.8

J20

ICD-10 Finland

Acute bronchitis

3.1

116.8

566

2043

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

114.4

2102

13743

R03BC03

ATC

nedocromil; inhalant

3.8

112.6

375

1070

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

8.3

111.6

149

186

DPA20

NOMESCO Finland

Trephine of frontal sinus

46.4

108.8

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

107.8

103

J32

ICD-10 Finland

Chronic sinusitis

11.9

106.9

109

R03DX09

ATC

mepolizumab; parenteral

+∞

105.7

101

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

104.6

100

XG405

NOMESCO Finland

Education on PEF monitoring

10.5

103.9

115

112

3028

Kela drug reimbursment

Mepolizumab

+∞

103.6

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

215.6

102.0

105

R01AD59

ATC

mometasone, combinations; nasal

3.4

101.6

394

1240

R03BB07

ATC

umeclidinium bromide; inhalant

14.5

101.6

J01DC02

ATC

cefuroxime; systemic

3.7

101.3

338

964

A02BC02

ATC

pantoprazole; systemic

2.2

101.3

2958

22528

R09

ICPC

Sinus symptom/complaint

3.1

99.9

454

1573

ZXD20

NOMESCO Finland

Day surgery

2.6

99.8

665

2827

4732A

ICD-9 Finland

Chronic sinusitis, Ethmoidal

122.1

99.5

107

Z3231

NOMESCO Finland

Registered nurse

2.1

98.8

1246

6975

R03AC04

ATC

fenoterol; inhalant

42.8

98.4

J33.1

ICD-10 Finland

Polypoid sinus degeneration

174.4

97.7

102

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.2

97.5

207

416

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.8

97.2

552

2162

SPAT1058

SPAT

PEF monitoring instruction

3.3

96.4

400

1312

A07AA02

ATC

nystatin; oral

3.7

95.1

326

946

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

94.2

1656

10428

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

93.7

461

1669

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

46.5

93.5

R03AK03

ATC

[U] fenoterol and ipratropium bromide

4.2

92.5

254

629

J01DB01

ATC

cefalexin; oral

2.5

92.4

3455

28438

H66.0

ICD-10 Finland

Acute suppurative otitis media

3.3

92.4

381

1244

ZXE00

NOMESCO Finland

One hour or less

2.0

92.0

1673

10637

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

91.8

1073

5807

J01

ICD-10 Finland

Acute sinusitis

3.6

91.5

325

965

297, ,

Kela drug reimbursment

+∞

91.0

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

5.8

90.8

171

308

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.1

90.8

194

392

DHB40

NOMESCO Finland

Conchotomy

24.6

89.0

Z2221

NOMESCO Finland

Medical doctor

2.1

88.7

1214

6959

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

6.8

88.4

140

212

S01GX01

ATC

cromoglicic acid; ophthalmic

2.3

87.4

849

4255

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

4.2

87.3

241

599

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

85.0

1556

9846

Z51.6

ICD-10 Finland

Desensitization to allergens

12.6

84.7

WX002

NOMESCO Finland

Sedation and analgesia

2.2

83.7

911

4772

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

83.4

432

1605

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.9

83.3

261

711

SPAT1059

SPAT

Spirometry at the office

3.8

82.2

263

727

R05

ICPC

Cough

2.1

82.1

1095

6189

A01AB09

ATC

miconazole; local oral

2.9

81.1

406

1480

4719X

ICD-9 Finland

Nasal polyps, Unspecified nasal polyp

211.8

80.6

J01MA12

ATC

levofloxacin; systemic

2.2

80.2

872

4557

TGC00

NOMESCO Finland

Bronchial lavation

5.0

79.8

176

365

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

79.7

1167

6809

UDC00

NOMESCO Finland

Ear microscopy

2.9

78.6

409

1522

J01DA01

ATC

[U] cefalexin

1.9

78.3

2523

18967

R74

ICPC

Upper respiratory infection acute

1.9

77.4

1330

8183

R75

ICPC

Sinusitis acute/chronic

3.5

77.1

274

812

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.9

73.5

167

355

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.0

73.3

339

1180

50501

ICD-8 Finland

Nasal polyp, Maxillaris

31.7

72.2

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

19.6

72.0

J01MA02

ATC

ciprofloxacin; systemic

1.8

71.8

1672

11264

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

11.6

70.7

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.9

69.9

216

582

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.0

69.8

206

537

A02BC05

ATC

esomeprazole; systemic

1.8

68.6

1702

11643

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

15.7

68.4

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

6.2

68.3

117

192

R01AD

ATC

Corticosteroids

7.7

67.9

128

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.6

67.4

165

373

H02AB09

ATC

hydrocortisone; systemic

4.8

65.8

150

320

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.9

65.3

196

517

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

65.1

1396

9104

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

64.7

1178

7301

G47.3

ICD-10 Finland

Sleep apnoea

1.9

62.8

1040

6244

R01AC01

ATC

cromoglicic acid; nasal

4.0

62.5

185

483

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

6.0

62.4

111

189

50304

ICD-8 Finland

Chronic sinusitis, Ethmoidalis

87.8

62.1

ZXC60

NOMESCO Finland

Application of heat

5.4

62.1

123

232

H66.9

ICD-10 Finland

Otitis media, unspecified

2.9

61.9

302

1081

A01AB04

ATC

amphotericin B; local oral

3.5

61.7

225

677

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

61.3

623

3141

R05

ICD-10 Finland

Cough

1.9

60.9

921

5359

GX1C5, ,

SPAT

11.2

60.6

3027

Kela drug reimbursment

Benralizumab

+∞

60.6

R03DX10

ATC

benralizumab; systemic

+∞

60.6

251, ,

Kela drug reimbursment

+∞

59.5

J01DA08

ATC

[U] cefaclor

2.4

59.2

444

1968

J02AC01

ATC

fluconazole; systemic

1.7

58.7

1495

10178

R07

ICPC

Sneezing/nasal congestion

2.8

58.4

305

1132

R08

ICPC

Nose symptom/complaint other

3.5

58.3

208

617

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

58.2

1809

13004

N02AX02

ATC

tramadol; systemic, rectal

1.7

58.0

1776

12710

N02BE01

ATC

paracetamol; systemic, rectal

2.3

57.5

3626

32024

4211

FHL

Transeptal septal resection and reconstruction

7.5

56.8

112

R01BA51

ATC

phenylpropanolamine, combinations; oral

2.3

56.7

480

2241

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

56.6

1200

7734

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

55.6

337

1350

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

55.2

259

906

50708

ICD-8 Finland

Hay fever, Alia definita

12.1

54.8

A02BC01

ATC

omeprazole; systemic

1.8

54.6

1090

6887

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.9

54.3

164

434

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

54.0

1780

12915

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

4.6

53.7

128

283

SPAT1057

SPAT

Peak expiratory flow measurement

5.3

53.3

108

208

DHB10

NOMESCO Finland

Excision of lesion of internal nose

13.0

52.0

M05BA04

ATC

alendronic acid; oral

2.4

51.2

376

1648

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

6.0

51.1

155

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

51.0

315

1273

R81

ICPC

Pneumonia

3.3

50.7

201

637

A02BC03

ATC

lansoprazole; oral

1.7

48.9

1134

7442

A03

ICPC

Fever

1.9

48.6

690

3899

J01FF01

ATC

clindamycin; systemic

1.7

48.3

1108

7244

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

6.1

47.9

141

GD1AA, ,

SPAT

1.9

47.9

686

3887

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

47.9

973

6145

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

6.7

47.6

116

H65.0

ICD-10 Finland

Acute serous otitis media

4.6

47.4

113

250

T78.4

ICD-10 Finland

Allergy, unspecified

3.1

47.3

202

669

R06AX12

ATC

terfenadine; oral

3.0

46.8

216

748

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

8.4

46.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

46.6

1403

9842

J30.0

ICD-10 Finland

Vasomotor rhinitis

3.7

45.9

151

424

R03CC02

ATC

salbutamol; systemic

3.3

45.6

177

553

Z3226

NOMESCO Finland

Physiotherapist

1.9

45.6

733

4305

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.3

45.6

120

287

50499

ICD-8 Finland

Deflected nasal septum

4.6

45.5

109

242

E0000UV, ,

ATC

1.6

45.2

1605

11705

50709

ICD-8 Finland

Hay fever, Unspecified

9.2

43.9

R4110

NOMESCO Finland

Physiotherapy

1.7

43.9

1119

7494

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

43.8

H01

ICPC

Ear pain/earache

2.1

43.6

472

2418

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

43.6

2832

23767

D07AC01

ATC

betamethasone; topical

1.6

42.5

1451

10438

R01BA01

ATC

phenylpropanolamine; oral

2.6

42.2

253

1006

UJF32

NOMESCO Finland

Coloscopy

1.7

42.0

1050

6983

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

41.7

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

8.8

41.4

Z71.8

ICD-10 Finland

Other specified counselling

1.6

41.3

1333

9444

R06.5

ICD-10 Finland

Mouth breathing

2.1

41.3

408

2017

R03DA05

ATC

aminophylline; systemic, rectal

9.2

41.3

M79.6

ICD-10 Finland

Pain in limb

1.6

41.1

1728

13026

ZX112

NOMESCO Finland

Subcutaneous

3.7

40.4

132

369

R01AC02

ATC

levocabastine; nasal

3.6

39.9

133

377

R29

ICPC

Respiratory symptom/complaint other

2.4

38.8

296

1315

R06AX18

ATC

acrivastine; oral

3.5

38.4

136

401

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.1

38.3

169

570

ZXA05

NOMESCO Finland

Left side

1.7

37.9

941

6220

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

8.7

37.9

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

37.5

1169

8173

R01AC07

ATC

nedocromil; nasal

10.6

37.5

D07AC13

ATC

mometasone; topical

1.6

37.2

1113

7706

I45.9

ICD-10 Finland

Conduction disorder, unspecified

7.1

36.8

J01DA09

ATC

[U] cefadroxil

1.6

36.6

1001

6771

J37.0

ICD-10 Finland

Chronic laryngitis

3.1

36.4

157

523

L17

ICPC

Foot/toe symptom/complaint

1.6

36.3

1205

8539

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.3

35.7

136

420

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

35.6

742

4672

DM1QA, ,

SPAT

2.8

35.6

187

695

WX402

NOMESCO Finland

General anaesthesia

1.6

35.3

910

6060

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

12.2

35.0

4618A

ICD-9 Finland

Acute sinusitis, Other acute sinusitis

14.0

34.8

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

34.2

599

3584

4738X

ICD-9 Finland

Chronic sinusitis, Other chronic sinusitis

57.7

34.2

50509

ICD-8 Finland

Nasal polyp, Unspecified

65.6

34.0

SPAT1325

SPAT

Vaccination

1.6

33.8

1193

8545

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

33.7

161

568

ZXA00

NOMESCO Finland

Right side

1.6

33.7

994

6829

R03

ICPC

Wheezing

5.4

33.5

124

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

33.3

327

1610

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

33.1

523

3032

L20.0

ICD-10 Finland

Besnier prurigo

2.3

32.9

264

1198

R83

ICPC

Respiratory infection other

1.6

32.7

910

6158

R03AC19

ATC

olodaterol

11.4

32.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

31.8

384

2037

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

31.7

327

1639

R60.0

ICD-10 Finland

Localized oedema

1.8

31.7

500

2896

DFF00

NOMESCO Finland

Pure tone audiometry

1.9

31.6

447

2501

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

31.3

761

4973

R05CB01

ATC

acetylcysteine; inhalant, oral

4.9

31.1

140

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

31.1

1104

7893

R51.80

ICD-10 Finland

Headache

1.8

30.9

574

3486

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

8.1

30.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

30.6

858

5805

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.0

30.2

134

454

R03BA07

ATC

mometasone; inhalant

6.8

30.1

R50.9

ICD-10 Finland

Fever, unspecified

1.7

30.0

589

3634

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

29.6

300

1494

S18

ICPC

Laceration/cut

1.5

29.6

1825

14571

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

29.0

1080

7780

R49.08

ICD-10 Finland

Other specified dysphonia

3.4

28.9

105

315

R01AX03

ATC

ipratropium bromide; nasal

3.4

28.8

106

321

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

28.7

396

2196

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

11.2

28.4

DM1AI, ,

SPAT

6.1

28.4

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

28.4

454

2635

D07AB08

ATC

desonide; topical

1.9

28.0

398

2227

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

27.9

393

2192

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

27.9

794

5377

WQ000

NOMESCO Finland

Hyposensibilisation

9.0

27.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

27.7

970

6886

R49.01

ICD-10 Finland

Functional dysphonia

3.0

27.7

125

428

1210

FHL

Anthroscopy

10.1

27.4

XQ820

NOMESCO Finland

Exposure to medicinal substance

8.8

27.2

DPB00

NOMESCO Finland

Partial excision of frontal sinus

38.1

27.1

R04.2

ICD-10 Finland

Haemoptysis

2.7

26.5

145

550

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

26.4

234

1105

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

5.4

26.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

26.3

1568

12349

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.2

26.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

26.2

668

4397

WZC30

NOMESCO Finland

Teaching

1.6

25.7

647

4246

E000002, ,

ATC

1.9

25.6

374

2108

P01AB01

ATC

metronidazole; oral, rectal

1.4

25.4

1430

11123

GX1E5, ,

SPAT

4.3

25.3

149

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

25.1

643

4234

J01FA01

ATC

erythromycin; systemic

1.7

25.1

464

2805

A46

ICD-10 Finland

Erysipelas

1.7

25.1

562

3578

SPAT1036

SPAT

Maxillary puncture

9.7

25.0

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

4.9

24.8

111

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

6.0

24.6

K02.1

ICD-10 Finland

Caries of dentine

1.4

24.5

2194

18491

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

24.5

562

3601

L04AX01

ATC

azathioprine; systemic

2.4

24.4

174

750

J01.8

ICD-10 Finland

Other acute sinusitis

6.1

24.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

24.2

598

3903

J02AC02

ATC

itraconazole; systemic

1.6

24.1

651

4340

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

23.9

365

2085

D07AA02

ATC

hydrocortisone; topical

1.7

23.8

471

2900

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

23.8

389

2269

A01AB10

ATC

natamycin; local oral

2.9

23.6

112

394

M25.5

ICD-10 Finland

Pain in joint

1.4

23.6

1217

9282

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

9.4

23.5

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

23.4

2063

17281

L50.9

ICD-10 Finland

Urticaria, unspecified

2.5

23.3

150

617

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.5

23.3

146

593

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

23.3

673

4555

J98.1

ICD-10 Finland

Pulmonary collapse

6.1

23.3

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

23.2

1295

10019

L50.8

ICD-10 Finland

Other urticaria

3.4

23.1

248

R05CB02

ATC

bromhexine; systemic

4.0

23.0

169

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

22.8

2695

23686

51920

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis eosinophilica

231.3

22.6

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

9.4

22.6

A02BA02

ATC

ranitidine; systemic

1.6

22.6

670

4558

R95

ICPC

Chron obstructive pulmonary disease

2.8

22.4

114

417

R42

ICD-10 Finland

Dizziness and giddiness

1.5

22.4

822

5857

H26.3

ICD-10 Finland

Drug-induced cataract

6.2

22.4

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

22.1

236

1196

R21

ICPC

Throat symptom/complaint

1.6

22.1

679

4656

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.7

21.9

107

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

21.9

1688

13768

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.6

21.7

204

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

21.6

785

5578

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

21.5

1164

8927

C03CA01

ATC

furosemide; systemic

1.4

21.4

1012

7573

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.4

21.3

49099

ICD-8 Finland

Bronchitis, unspecified

4.7

21.2

106

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

20.9

650

4463

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

20.9

471

2998

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

3.2

20.7

255

D19

ICPC

Teeth/gum symptom/complaint

1.4

20.5

1104

8448

D07AD01

ATC

clobetasol; topical

1.5

20.5

621

4239

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.9

20.4

326

4225

FHL

Exploratory buccal opening, includes polyps and cyst removal

7.2

20.3

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

20.3

400

2456

Z01.7

ICD-10 Finland

Laboratory examination

1.5

20.2

625

4282

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

20.1

2436

21249

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

20.0

1091

8359

R01AD04

ATC

flunisolide; nasal

5.0

20.0

SFA20

NOMESCO Finland

Two-surface restoration

1.4

19.9

2170

18604

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

19.9

218

1116

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

19.8

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.3

19.4

114

R97

ICPC

Allergic rhinitis

3.3

19.4

230

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

19.4

327

1923

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

19.4

670

4701

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

31.4

19.2

E000003, ,

ATC

2.2

19.1

155

706

H92.0

ICD-10 Finland

Otalgia

2.0

19.1

225

1181

E000001, ,

ATC

1.5

19.1

649

4536

SFA10

NOMESCO Finland

One-surface restoration

1.4

19.0

2015

17146

C07AB07

ATC

bisoprolol; oral

1.4

19.0

1760

14672

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

19.0

276

1552

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

18.9

1366

10951

R78

ICPC

Acute bronchitis/bronchiolitis

3.1

18.8

265

49308

ICD-8 Finland

Asthma, Alia definita

+∞

18.8

R03CC03

ATC

terbutaline; systemic

3.5

18.6

186

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

18.6

1487

12108

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

18.5

1105

8581

XQ802

NOMESCO Finland

Epicutan test

2.3

18.5

147

665

M03BX02

ATC

tizanidine; oral

1.3

18.5

2273

19748

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.5

18.4

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.6

18.4

105

408

H70.1

ICD-10 Finland

Chronic mastoiditis

7.9

18.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

18.2

616

4296

C09CA06

ATC

candesartan; oral

1.4

18.2

875

6536

R06AX11

ATC

astemizole; oral

2.6

18.2

102

393

R53

ICD-10 Finland

Malaise and fatigue

1.4

18.1

859

6404

J01DC04

ATC

cefaclor; oral

3.9

18.0

134

XG466

NOMESCO Finland

Sleep oxymetry

2.5

18.0

116

478

L50.0

ICD-10 Finland

Allergic urticaria

2.7

18.0

372

N05BB01

ATC

hydroxyzine; systemic

2.0

18.0

207

1078

M54.5

ICD-10 Finland

Low back pain

1.4

18.0

1290

10312

S21

ICPC

Skin texture symptom/complaint

1.5

17.9

558

3824

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

7.6

17.8

K07

ICPC

Swollen ankles/oedema

2.1

17.8

174

854

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.0

17.8

269

A02BC04

ATC

rabeprazole; oral

1.7

17.7

316

1886

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

17.7

928

7035

344

Kela drug reimbursment

Omalizumab

20.1

17.7

R2110

NOMESCO Finland

Giving the first information

1.9

17.6

227

1228

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

17.5

315

GX2C5

NOMESCO Finland

Short-lasting oximetry

5.3

17.5

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

17.5

1552

12807

R52.9

ICD-10 Finland

Pain, unspecified

1.7

17.3

369

2310

SPAT1254

SPAT

Administration of medicine

1.6

17.3

471

3130

R06AE08, ,

ATC

4.4

17.3

B37.0

ICD-10 Finland

Candidal stomatitis

4.1

17.3

116

R03DB04

ATC

theophylline and adrenergics; systemic

21.0

17.3

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.8

17.3

323

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

17.2

915

6948

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

17.2

642

4564

A97

ICPC

No disease

1.5

16.9

715

5206

R43.0

ICD-10 Finland

Anosmia

4.2

16.9

105

L03

ICPC

Low back symptom/complaint

1.4

16.9

1022

7931

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

3.0

16.8

245

R03DX05

ATC

omalizumab; parenteral

21.9

16.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

16.8

1093

8582

SFA30

NOMESCO Finland

Three-surface restoration

1.3

16.8

1574

13068

48609

ICD-8 Finland

Pneumonia, unspecified

3.3

16.8

199

WW200

NOMESCO Finland

Immunization

2.5

16.7

106

434

49309

ICD-8 Finland

Asthma, Unspecified

+∞

16.7

DGW00

NOMESCO Finland

Dilatation of eustachian tube

12.7

16.6

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.6

16.6

147

N03AX12

ATC

[U] gabapentin; oral

1.5

16.5

550

3820

ZXC99

NOMESCO Finland

Other special technic in surgery

13.4

16.4

Z2446

NOMESCO Finland

Social worker

1.9

16.4

213

1155

L12

ICPC

Hand/finger symptom/complaint

1.5

16.4

604

4283

A98

ICPC

Health maint/preventive medicine

1.9

16.3

3824

36684

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

16.3

415

2715

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.0

16.3

250

R13

ICD-10 Finland

Dysphagia

1.8

16.2

257

1483

S29

ICPC

Skin symptom/complaint other

1.4

16.1

730

5380

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

16.1

2455

21786

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

16.0

1353

11045

J01CA02

ATC

pivampicillin; oral

2.4

15.8

111

476

A92

ICPC

Allergy/allergic reaction NOS

2.5

15.8

391

N03AX16

ATC

[U] pregabalin

1.4

15.8

786

5890

P06

ICPC

Sleep disturbance

1.6

15.7

442

2958

M05BA07

ATC

risedronic acid; oral

2.5

15.7

387

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

15.6

215

1188

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

15.6

452

3045

F2680, ,

NOMESCO Finland

26.4

15.6

N01

ICPC

Headache

1.6

15.4

338

2130

SPAT1263

SPAT

Sampling

1.3

15.4

1403

11562

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

15.3

272

1623

R01AC03

ATC

azelastine; nasal

7.0

15.3

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

15.2

415

2756

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

15.2

658

4804

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

28.7

15.2

L50.3

ICD-10 Finland

Dermatographic urticaria

3.0

15.1

223

EB1AA, ,

SPAT

1.8

15.0

234

1343

R50

ICPC

Respiratory, Medication/prescr/renewal

14.0

15.0

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

15.0

628

4559

SPAT1255

SPAT

Intravenous administration of medicine

1.8

14.9

239

1384

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.9

14.9

230

R11

ICD-10 Finland

Nausea and vomiting

1.7

14.9

287

1750

C08DA01

ATC

verapamil; systemic

2.1

14.8

136

653

L15

ICPC

Knee symptom/complaint

1.4

14.8

885

6834

X58

ICD-10 Finland

Exposure to other specified factors

1.5

14.8

516

3614

A07EA06

ATC

budesonide; oral, local oral

2.1

14.8

135

647

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

14.7

754

5673

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

4.1

14.7

WX290

NOMESCO Finland

Other blockage of nerve

1.3

14.7

1648

13954

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.3

14.6

165

S01GX02

ATC

levocabastine; ophthalmic

1.9

14.6

175

925

DPB20

NOMESCO Finland

Obliteration of frontal sinus

+∞

14.6

R03DX11

ATC

tezepelumab; systemic

+∞

14.6

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

14.6

154

779

L16

ICPC

Ankle symptom/complaint

1.6

14.6

410

2742

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

14.6

334

2129

J01MA01

ATC

ofloxacin; systemic

1.7

14.5

282

1722

D11

ICPC

Diarrhoea

1.6

14.5

394

2613

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

14.5

467

3215

K30

ICD-10 Finland

Functional dyspepsia

1.6

14.5

387

2557

4718X

ICD-9 Finland

Nasal polyps, Other polyp of sinus

150.5

14.5

D02AE01

ATC

carbamide; topical

1.8

14.4

211

1190

Z01.2

ICD-10 Finland

Dental examination

1.3

14.4

1630

13806

DC1AD

NOMESCO Finland

Temporalbone CT

3.4

14.4

147

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

14.3

404

2704

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

14.3

993

7844

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

2.6

14.2

321

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.7

14.2

281

G04CA02

ATC

tamsulosin; oral

1.4

14.2

867

6711

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

14.2

431

2931

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

14.1

319

2025

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

14.1

321

2041

N05CF01

ATC

zopiclone; oral

1.3

14.0

1078

8641

H71

ICPC

Acute otitis media/myringitis

3.5

14.0

135

A04

ICPC

Weakness/tiredness general

1.5

14.0

516

3653

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

13.9

198

1106

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.3

13.9

155

L04AX03

ATC

methotrexate; systemic

1.6

13.9

336

2169

J01MA06

ATC

norfloxacin; oral

1.5

13.9

415

2812

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

13.9

132

643

G50.1

ICD-10 Finland

Atypical facial pain

2.8

13.8

251

H29

ICPC

Ear symptom/complaint other

1.5

13.8

431

2947

J42

ICD-10 Finland

Unspecified chronic bronchitis

3.6

13.8

122

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

13.8

180

979

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

13.7

434

2975

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

13.7

361

2377

KMAK, ,

NOMESCO Finland

1.3

13.7

1775

15270

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

13.7

917

7198

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

13.7

966

7643

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

13.6

159

833

D01BA02

ATC

terbinafine; oral

1.4

13.6

925

7275

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

13.5

949

7497

S97

ICPC

Chronic ulcer skin

1.8

13.5

221

1287

F29

ICPC

Eye symptom/complaint other

1.6

13.5

368

2443

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.0

13.5

146

746

3DX05, ,

NOMESCO Finland

140.5

13.5

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.7

13.4

278

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.3

13.4

435

N17

ICPC

Vertigo/dizziness

1.5

13.4

432

2976

4720A

ICD-9 Finland

Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS CHRONICA HYPERTROPHICA]

25.8

13.4

E000007, ,

ATC

1.9

13.3

163

868

Y0499

ICD-8 Finland

Investigation of respiratory system

3.9

13.3

102

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

13.3

103

462

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

13.3

456

3179

C08DB01

ATC

diltiazem; oral

1.9

13.2

153

801

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.5

13.1

340

G44.2

ICD-10 Finland

Tension-type headache

1.5

13.1

427

2944

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

13.1

186

1039

DM1AA, ,

SPAT

2.9

13.1

214

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.1

1306

10840

J01X

ATC

OTHER ANTIBACTERIALS

4.8

13.1

4212

FHL

Maxillapremmaxilla opening septum resection and reconstruction

4.5

13.0

R48

ICPC

Respiratory, Clarification/discussion RFE/demand

4.6

13.0

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

13.0

3048

32452

A03FA02

ATC

cisapride; oral, rectal

1.7

12.9

228

1359

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.8

12.9

100

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

12.9

232

1390

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

12.7

239

1449

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

12.6

204

1185

XG460

NOMESCO Finland

Short time oxymetry

3.0

12.6

186

A99

ICPC

Disease/condition unspecnature/site

1.5

12.6

366

2463

J05AH02

ATC

oseltamivir; oral

4.6

12.6

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

12.6

167

914

EB1SA, ,

SPAT

1.9

12.6

170

936

T78.3

ICD-10 Finland

Angioneurotic oedema

2.9

12.5

192

L28

ICPC

Limited function/disability (L)

1.4

12.5

634

4750

K11.2

ICD-10 Finland

Sialoadenitis

2.1

12.5

122

601

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

12.4

608

4526

DNW99

NOMESCO Finland

Other operation on ethmoidal sinus and bone

130.4

12.4

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

12.3

216

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

10.5

12.2

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

12.2

174

974

R49.09

ICD-10 Finland

Unspecified dysphonia

3.3

12.2

133

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.9

12.1

N06AX11

ATC

mirtazapine; oral

1.3

12.1

1141

9379

U02

ICPC

Urinary frequency/urgency

1.4

12.1

476

3409

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

12.0

456

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.0

12.0

170

H01.0

ICD-10 Finland

Blepharitis

1.7

12.0

229

1394

ZX120

NOMESCO Finland

Intravenous

1.6

12.0

315

2074

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

11.9

261

1644

R04.0

ICD-10 Finland

Epistaxis

1.6

11.9

259

1630

RK320, ,

NOMESCO Finland

3.8

11.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

11.8

283

1822

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.7

11.8

233

1430

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.8

821

6464

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

11.7

206

1226

B01AB05

ATC

enoxaparin; parenteral

1.3

11.6

1071

8764

R03BB02

ATC

oxitropium bromide; inhalant

5.5

11.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

11.6

358

2440

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

11.6

420

2960

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

11.5

793

6227

B01AC04

ATC

clopidogrel; oral

1.4

11.5

558

4143

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

11.5

359

2455

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.4

11.5

307

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

11.4

224

1372

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

11.4

445

3177

N06AB04

ATC

citalopram; systemic

1.4

11.4

649

4948

A01

ICPC

Pain general/multiple sites

1.5

11.4

331

2226

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.4

2241

20095

S04

ICPC

Lump/swelling localized

1.5

11.4

366

2515

N06AX21

ATC

duloxetine; oral

1.5

11.4

383

2657

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

11.4

316

2105

S51.8

ICD-10 Finland

Open wound of other parts of forearm

3.1

11.4

149

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

11.4

534

3945

S22.3

ICD-10 Finland

Fracture of rib

1.6

11.4

257

1633

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

11.3

1637

14161

D09AB01

ATC

zinc bandage without supplements; topical

2.5

11.3

285

J04.0

ICD-10 Finland

Acute laryngitis

2.1

11.3

105

508

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

11.3

451

3237

R07.3

ICD-10 Finland

Other chest pain

1.5

11.3

348

2373

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

35.1

11.3

4710A

ICD-9 Finland

Nasal polyps, Polyp of nasal cavity

35.1

11.3

B37.08

ICD-10 Finland

Other candidal stomatitis

3.5

11.2

110

R07.0

ICD-10 Finland

Pain in throat

1.7

11.2

224

1379

S16

ICPC

Bruise/contusion

2.1

11.2

102

489

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

11.2

122

625

D01

ICPC

Abdominal pain/cramps general

1.5

11.2

389

2718

48509

ICD-8 Finland

Bronchopneumonia, unspecified

3.1

11.1

151

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

11.1

481

3502

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

11.1

257

1644

J01AA04

ATC

lymecycline; systemic

1.5

11.0

399

2810

R43

ICPC

Respiratory, Other diagnostic procedure

4.3

11.0

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

11.0

362

2501

E000006, ,

ATC

1.7

11.0

205

1240

A23

ICPC

Risk factor NOS

1.5

10.9

305

2037

GX1K5

NOMESCO Finland

Diffusion capacity

4.1

10.9

SPAT1260

SPAT

Consultation of another employee

1.4

10.8

549

4107

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

15.5

10.8

WX110, ,

SPAT

1.7

10.7

185

1095

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

10.7

200

1210

R49.03

ICD-10 Finland

Atrophic dysphonia

3.0

10.7

160

L95

ICPC

Osteoporosis

1.9

10.7

130

693

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

10.6

408

2904

-1, ,

NOMESCO Finland

1.3

10.6

1068

8822

DHB30

NOMESCO Finland

Polypectomy of choana through maxillary antrum

60.2

10.6

J05AB11

ATC

valaciclovir; oral

1.4

10.6

477

3498

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

10.5

270

1767

DM1CI

NOMESCO Finland

Very extensive cone beam CT of paranasal sinus

8.5

10.5

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

10.5

413

2953

R04

ICPC

Breathing problem other

1.9

10.5

132

711

DMW00

NOMESCO Finland

Intubation of maxillary antrum

9.2

10.5

L01

ICPC

Neck symptom/complaint

1.4

10.5

526

3927

RK110, ,

NOMESCO Finland

4.0

10.5

L30.3

ICD-10 Finland

Infective dermatitis

2.0

10.5

116

599

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

10.4

769

6092

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

10.4

286

1901

49320, ,

ICD-8 Finland

+∞

10.4

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

10.4

349

2421

S01GX08

ATC

ketotifen; ophthalmic

1.9

10.4

135

735

R25.2

ICD-10 Finland

Cramp and spasm

2.2

10.4

379

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

10.3

153

868

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

10.3

408

2924

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

4.4

10.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

10.2

269

1772

ZX109, ,

SPAT

4.0

10.2

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

10.2

344

2388

S02

ICPC

Pruritus

2.0

10.2

114

591

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.2

10.2

382

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

10.2

1074

8921

J05AB01

ATC

aciclovir; systemic

1.3

10.1

713

5608

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

10.1

327

2250

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

2.4

10.1

288

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

10.1

312

2128

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

10.1

255

1665

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.7

10.0

166

972

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

5.0

10.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

10.0

368

2597

R35

ICD-10 Finland

Polyuria

1.6

10.0

240

1547

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

10.0

214

1343

4122

FHL

Tympanostomy (tympanic tube)

3.3

10.0

114

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

40.2

10.0

UJD10, ,

SPAT

2.1

10.0

438

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

9.9

452

3322

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.2

9.8

115

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

9.8

243

1578

A07EC02

ATC

mesalazine; oral, rectal

1.7

9.8

174

1040

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

9.8

235

1516

K51.5

ICD-10 Finland

Left sided colitis

2.0

9.8

475

D06

ICPC

Abdominal pain localized other

1.5

9.8

278

1863

U13

ICPC

Bladder symptom/complaint other

2.0

9.7

496

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

9.7

161

943

J43.9

ICD-10 Finland

Emphysema, unspecified

2.6

9.7

203

XKD00

NOMESCO Finland

Uroflowmetry

1.4

9.7

545

4142

DFF15

NOMESCO Finland

Speech audiometry

1.7

9.7

171

1020

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.9

9.7

153

L12.0

ICD-10 Finland

Bullous pemphigoid

3.9

9.7

A11

ICPC

Chest pain NOS

1.5

9.6

288

1950

50700, ,

ICD-8 Finland

55.1

9.6

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

9.6

281

1893

R05CA10

ATC

expectorants - combinations

2.4

9.6

270

M79.1

ICD-10 Finland

Myalgia

1.4

9.6

474

3527

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

9.6

212

1341

TDA90

NOMESCO Finland

Removal wax from ear

2.6

9.6

199

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

9.6

268

1790

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.0

9.6

138

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.8

9.5

C05AA08

ATC

fluocortolone; rectal, topical

1.4

9.5

442

3255

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.5

265

1769

DNB30

NOMESCO Finland

Excision of lesion of ethmoidal sinus

17.6

9.4

3089, ,

Kela drug reimbursment

+∞

9.4

49330, ,

ICD-8 Finland

+∞

9.4

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.0

9.4

129

4451

FHL

Guitar cutting

2.3

9.3

280

XA420

NOMESCO Finland

Extensive sleep examination

2.9

9.3

140

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

9.3

103

532

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

9.3

383

2761

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

9.3

168

B01AF02

ATC

apixaban; oral

1.4

9.2

446

3307

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

3.8

9.2

H02

ICPC

Hearing complaint

1.4

9.2

498

3761

E66.8

ICD-10 Finland

Other obesity

1.7

9.2

162

966

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.1

9.1

413

A29

ICPC

General symptom/complaint other

1.4

9.1

440

3262

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.4

9.1

240

R12

ICD-10 Finland

Heartburn

1.5

9.1

270

1826

WX722

NOMESCO Finland

PEEP

1.7

9.1

149

871

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.1

9.1

121

DMA00

NOMESCO Finland

Biopsy of maxillary antrum

11.5

9.1

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.8

9.1

122

673

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

9.0

542

4159

N02BF01

ATC

gabapentin; oral

1.4

9.0

338

2394

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

15.6

9.0

J01XB01

ATC

colistin; inhalant, parenteral

36.8

9.0

L20

ICPC

Joint symptom/complaint NOS

1.8

9.0

124

689

N06AX16

ATC

venlafaxine; oral

1.4

9.0

424

3131

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.0

9.0

470

R03AC18

ATC

indacaterol; inhalant

3.8

8.9

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.8

8.9

149

R52.2

ICD-10 Finland

Other chronic pain

1.8

8.9

120

662

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.9

8.9

101

527

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

2.7

8.9

172

4781C

ICD-9 Finland

Other diseases of upper respiratory tract, Other diseases of nasal cavity and sinuses[CYSTA SINUS MAXILLARIS]

4.9

8.8

L13

ICPC

Hip symptom/complaint

1.3

8.8

637

5023

L30.8

ICD-10 Finland

Other specified dermatitis

2.0

8.8

480

AA1AD

NOMESCO Finland

CT of head and brain

1.3

8.8

976

8132

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.7

8.8

173

I45.0

ICD-10 Finland

Right fascicular block

3.5

8.8

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

8.8

776

6287

H57.1

ICD-10 Finland

Ocular pain

1.8

8.8

121

673

M48.0

ICD-10 Finland

Spinal stenosis

1.4

8.7

386

2818

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

8.7

477

3607

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

8.7

207

1332

N02AC04

ATC

dextropropoxyphene; oral

1.9

8.7

100

524

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

8.7

606

4756

XA421

NOMESCO Finland

Nocturnal polygraphy

4.2

8.6

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.7

8.6

139

809

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

8.6

832

6814

J01DB05

ATC

cefadroxil; oral

1.8

8.6

135

780

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.8

8.6

121

677

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.6

406

2999

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.2

8.6

323

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

8.6

256

1734

207

Kela drug reimbursment

Chronic arrhythmias

1.4

8.6

504

3855

M54.2

ICD-10 Finland

Cervicalgia

1.5

8.6

262

1784

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

8.6

376

J31.1

ICD-10 Finland

Chronic nasopharyngitis

3.1

8.5

115

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.0

8.5

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

8.5

244

1639

K80

ICPC

Cardiac arrhythmia NOS

1.5

8.5

286

1985

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.7

8.5

159

UJH02

NOMESCO Finland

Anoscopy

1.8

8.5

127

724

DHW99

NOMESCO Finland

Other operation on nose

27.6

8.5

J01GB01

ATC

tobramycin; inhalant, parenteral

27.6

8.5

D02AX

ATC

Other emollients and protectives

2.0

8.5

425

R07.1

ICD-10 Finland

Chest pain on breathing

2.4

8.5

224

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

8.4

307

2163

4223

FHL

Outeroid etomoidectomy

90.3

8.4

D01AC02

ATC

miconazole; topical

1.5

8.4

238

1595

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.7

8.4

143

847

DM1BI

NOMESCO Finland

Extensive cone beam CT of paranasal sinus

12.8

8.4

49310, ,

ICD-8 Finland

+∞

8.3

EB1HA, ,

SPAT

2.0

8.3

455

SDA03

NOMESCO Finland

Periodontal treatment

1.2

8.3

1395

12149

ZXD35

NOMESCO Finland

Usual procedure

1.9

8.3

518

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

8.3

365

2663

K07.60

ICD-10 Finland

Snapping jaw

1.7

8.3

144

857

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.3

742

6018

DKW40

NOMESCO Finland

Ligature of artery of internal nose

9.4

8.3

4227

FHL

Forehead cavity drainage

9.4

8.3

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

8.2

378

2778

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

8.2

387

2856

D06AX01

ATC

fusidic acid; topical

1.5

8.2

272

1882

G04CA01

ATC

alfuzosin; oral

1.4

8.2

439

3308

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.4

8.2

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

8.2

130

754

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.3

8.2

246

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

14.5

8.2

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.1

775

6334

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

8.1

714

5776

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

8.1

530

ZXC10

NOMESCO Finland

Use of laser

2.1

8.1

364

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

3.1

8.1

103

M02AA07

ATC

piroxicam; topical

1.2

8.1

1158

9914

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

8.1

Z50.1

ICD-10 Finland

Other physical therapy

1.6

8.1

165

1025

R39

ICPC

Respiratory, Physical function test

3.8

8.1

D11AH01

ATC

tacrolimus; topical

3.3

8.1

R03BB06

ATC

glycopyrronium bromide; inhalant

6.8

8.0

C09CA03

ATC

valsartan; oral

1.4

8.0

309

2200

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.5

8.0

278

1941

OAB44

NOMESCO Finland

General health guidance

8.9

8.0

L29

ICPC

Musculoskeletal sympt/complt other

1.5

8.0

283

1983

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

8.0

357

2610

WX320

NOMESCO Finland

Spinalanesthesy

1.3

8.0

811

6676

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

4.1

8.0

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.8

8.0

104

569

R28

ICPC

Limited function/disability (R)

2.7

8.0

159

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.9

485

3731

J15.8

ICD-10 Finland

Other bacterial pneumonia

3.3

7.9

L50

ICD-10 Finland

Urticaria

2.3

7.9

250

L05

ICPC

Flank/axilla symptom/complaint

1.5

7.9

212

1404

C08CA01

ATC

amlodipine; oral

1.2

7.9

1321

11487

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.9

7.9

471

K08.80

ICD-10 Finland

Toothache NOS

1.5

7.9

274

1915

F2682, ,

NOMESCO Finland

13.0

7.9

ZXD05

NOMESCO Finland

Urgent procedure

1.3

7.9

936

7848

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

7.9

348

2542

ZY010

NOMESCO Finland

Hospital outpatient

1.7

7.8

142

856

L28.1

ICD-10 Finland

Prurigo nodularis

3.2

7.8

XX9XW, ,

NOMESCO Finland

3.2

7.8

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.3

7.8

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

7.8

404

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

7.8

159

988

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

7.7

748

6119

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

7.7

292

2075

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

7.7

105

583

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

7.7

124

724

J01.3

ICD-10 Finland

Acute sphenoidal sinusitis

7.4

7.7

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.8

7.7

106

591

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

7.7

210

1398

M54

ICD-10 Finland

Dorsalgia

1.4

7.6

379

2821

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

7.6

118

680

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.7

7.6

151

PH2AE, ,

SPAT

2.1

7.6

353

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

7.6

156

971

120

Kela drug reimbursment

Hypogammaglobulinaemia

11.9

7.6

4731A

ICD-9 Finland

Chronic sinusitis, Frontal

25.0

7.6

SPAT1097

SPAT

Recording of ECG

1.3

7.6

449

3438

K85

ICPC

Elevated blood pressure

1.3

7.6

546

4300

R05DB20

ATC

other cough suppressants - combinations

1.6

7.5

154

957

315

Kela drug reimbursment

Clopidogrel

2.9

7.5

113

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

7.5

182

1178

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

7.5

288

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

7.5

556

4393

6123

FHL

Radical surgery

1.8

7.5

100

551

K90.0

ICD-10 Finland

Coeliac disease

1.9

7.5

473

M79.7

ICD-10 Finland

Fibromyalgia

1.9

7.5

466

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

3.0

7.5

103

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

7.4

266

1869

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

7.4

311

2249

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.2

7.4

283

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

7.4

205

1367

S01GX04

ATC

nedocromil; ophthalmic

2.4

7.4

207

WW200, ,

SPAT

1.2

7.4

1029

8767

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

7.4

145

892

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.1

7.4

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

7.4

303

2184

S01ED02

ATC

betaxolol; ophthalmic

3.2

7.4

N03

ICPC

Pain face

3.0

7.4

109

XF402

NOMESCO Finland

ECG with work load test

1.4

7.4

328

2398

L50.1

ICD-10 Finland

Idiopathic urticaria

3.3

7.4

S51.0

ICD-10 Finland

Open wound of elbow

2.5

7.3

178

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.0

7.3

372

4252

FHL

Resection, coagulation or cryo on the cortex and nasal mucosa

8.4

7.3

WX290, ,

SPAT

1.8

7.3

103

578

S50.1

ICD-10 Finland

Contusion of other and unspecified parts of forearm

2.7

7.3

143

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

3.0

7.3

3DX08, ,

NOMESCO Finland

+∞

7.3

4733A

ICD-9 Finland

Chronic sinusitis, Sphenoidal

+∞

7.3

4230

FHL

Forehead cavity radical cutting and filling

+∞

7.3

GX1C5

NOMESCO Finland

PEF monitoring for assessment of efficacy of asthma management

+∞

7.3

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.3

101

564

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

9.4

7.3

WX704

NOMESCO Finland

Intubation

1.5

7.3

261

1836

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

7.3

521

J04BA02

ATC

dapsone; oral

3.5

7.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

7.2

569

4532

D01AE15

ATC

terbinafine; topical

1.5

7.2

225

1539

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

7.2

233

1605

OAA65, ,

SPAT

1.3

7.2

510

4004

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.6

7.2

176

1143

RK250, ,

NOMESCO Finland

3.7

7.2

RK520, ,

NOMESCO Finland

4.5

7.2

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.0

7.2

368

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

30.1

7.1

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

2.7

7.1

128

S62.6

ICD-10 Finland

Fracture of other finger

1.6

7.1

139

855

R43.8

ICD-10 Finland

Other and unspecified disturbances of smell and taste

3.2

7.1

N05CF02

ATC

zolpidem; oral

1.3

7.1

530

4192

S81.0

ICD-10 Finland

Open wound of knee

2.2

7.1

243

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

7.1

164

1052

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.0

7.1

101

WVA20

NOMESCO Finland

Medicine administration

1.8

7.1

504

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.8

7.0

123

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.7

7.0

124

742

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.5

7.0

185

1222

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.0

206

1393

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

7.0

107

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.8

7.0

102

579

A13

ICPC

Concern/fear medical treatment

2.1

7.0

324

L18

ICPC

Muscle pain

1.7

7.0

130

790

EMB10

NOMESCO Finland

Tonsillectomy

1.6

7.0

141

875

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.8

7.0

528

L04AA06

ATC

mycophenolic acid; systemic

2.1

6.9

318

S51

ICD-10 Finland

Open wound of forearm

5.4

6.9

L08.0

ICD-10 Finland

Pyoderma

2.8

6.9

119

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

13.8

6.9

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

6.9

376

2843

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.9

6.9

451

UJF32, ,

SPAT

1.7

6.9

116

687

L08

ICPC

Shoulder symptom/complaint

1.3

6.9

770

6404

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

2.7

6.8

125

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

2.4

6.8

178

R51

ICD-10 Finland

Headache

1.6

6.8

152

966

K63.5

ICD-10 Finland

Polyp of colon

1.9

6.8

417

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.1

6.8

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.1

6.8

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

6.7

6.8

RK120, ,

NOMESCO Finland

6.7

6.8

S81

ICD-10 Finland

Open wound of lower leg

3.8

6.8

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.6

6.8

137

H05.0

ICD-10 Finland

Acute inflammation of orbit

10.9

6.8

XG420

NOMESCO Finland

Time-volume spirometry

10.9

6.8

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

6.8

229

1593

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.8

6.8

100

570

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

40.1

6.8

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

2.9

6.7

104

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.3

6.7

198

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

6.7

117

699

M05BX04

ATC

denosumab; parenteral

1.5

6.7

185

1235

ZYC03

NOMESCO Finland

Remote contact, text-based

3.4

6.7

R4130

NOMESCO Finland

Speech therapy

1.9

6.7

434

GD1PA, ,

SPAT

3.3

6.7

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.7

975

8337

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

6.7

565

50306

ICD-8 Finland

Chronic sinusitis, Pansinuitis chronica

22.5

6.7

50308

ICD-8 Finland

Chronic sinusitis, Alia definita

22.5

6.7

A05

ICPC

Feeling ill

1.6

6.7

153

980

SPAT1301

SPAT

No procedures

1.2

6.6

960

8201

WZC00, ,

SPAT

1.3

6.6

468

3673

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

6.6

146

926

D11AH02

ATC

pimecrolimus; topical

6.4

6.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

6.6

237

1667

Z00.0

ICD-10 Finland

General medical examination

1.3

6.6

596

4830

XCK00

NOMESCO Finland

Perimetry

1.5

6.6

178

1183

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

6.6

301

2213

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

3.3

6.5

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

6.5

161

1048

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.0

6.5

305

S01GX09

ATC

olopatadine; ophthalmic

1.9

6.5

409

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.9

6.5

374

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.2

6.5

239

H26.2

ICD-10 Finland

Complicated cataract

2.4

6.5

176

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

6.5

445

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.7

6.5

103

599

L20.8

ICD-10 Finland

Other atopic dermatitis

2.5

6.5

158

S22

ICPC

Nail symptom/complaint

1.5

6.5

215

1490

B07.9

ICD-10 Finland

Verruca simplex

1.7

6.5

106

622

K59.0

ICD-10 Finland

Constipation

1.6

6.5

162

1058

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.9

6.5

382

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

6.5

726

6035

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

6.4

348

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

1.9

6.4

376

4231

FHL

Sphenotomy

70.0

6.4

R03AL12

ATC

indacaterol, glycopyrronium bromide and mometasone; inhalant

70.0

6.4

C09CA01

ATC

losartan; oral

1.2

6.4

852

7210

N06AB10

ATC

escitalopram; oral

1.3

6.4

588

4775

R5120

NOMESCO Finland

Preparation of an aid

1.8

6.4

543

H93.1

ICD-10 Finland

Tinnitus

1.5

6.4

224

1571

H15.1

ICD-10 Finland

Episcleritis

2.3

6.4

203

B01AA03

ATC

warfarin; systemic

1.3

6.3

559

4515

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

6.3

160

I45.1

ICD-10 Finland

Other and unspecified right bundle-branch block

3.0

6.3

L87

ICPC

Bursitis/tendinitis/synovitis NOS

2.2

6.3

223

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.2

6.3

223

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

6.3

392

3022

ZFX00

NOMESCO Finland

Use of balloon dilatation

11.0

6.3

Z58.8

ICD-10 Finland

Other problems related to physical environment

11.0

6.3

DMB30

NOMESCO Finland

Transmaxillary excision of lesion of maxillary antrum

11.0

6.3

DKW99

NOMESCO Finland

Other procedures for control of epistaxis

5.5

6.3

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

6.3

631

5177

ZXB87

NOMESCO Finland

Balloon dilation, paranasal sinuses

9.3

6.3

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.5

6.3

SFA00

NOMESCO Finland

Small restoration

1.3

6.3

444

3486

L02

ICPC

Back symptom/complaint

1.4

6.3

299

2213

W19

ICD-10 Finland

Unspecified fall

1.4

6.3

295

2179

4460B

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Polyarteritis nodosa[POLYARTERITIS NODOSA CUM INFILTRATIONE PULMONUM]

+∞

6.2

AAE05

NOMESCO Finland

Nasoendoscopic closure of cerebrospinal fluid fistula

+∞

6.2

DNB00

NOMESCO Finland

External ethmoidectomy

+∞

6.2

4AC06, ,

NOMESCO Finland

+∞

6.2

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

6.2

127

791

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

6.2

208

1445

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

6.2

175

1174

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

6.2

1333

11810

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.2

685

5682

R00.2

ICD-10 Finland

Palpitations

1.4

6.2

230

1630

SPAT1283

SPAT

Restricted health certificate

1.3

6.2

423

3305

G01AF05

ATC

econazole; vaginal

1.5

6.2

194

1331

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.2

219

1539

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

5.0

6.2

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.6

6.2

137

872

C03DA01

ATC

spironolactone; oral

1.3

6.1

362

2769

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

6.1

140

896

R10.0

ICD-10 Finland

Acute abdomen

1.7

6.1

550

D02

ICPC

Abdominal pain epigastric

1.5

6.1

182

1235

K04

ICPC

Palpitations/awareness of heart

1.5

6.1

161

1065

SPAT1360

SPAT

Extensive global examination

1.5

6.1

195

1343

SBA00

NOMESCO Finland

Microbiological examinations

1.9

6.1

419

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

2.2

6.1

220

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

6.1

132

835

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

6.1

412

F1246, ,

NOMESCO Finland

12.5

6.1

DKW20

NOMESCO Finland

Packing of posterior cavity of nose

12.5

6.1

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

12.5

6.1

P03

ICPC

Feeling depressed

1.4

6.1

252

1822

E66.00

ICD-10 Finland

Metabolic syndrome

1.5

6.1

167

1115

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.7

6.1

116

711

H10

ICD-10 Finland

Conjunctivitis

1.5

6.1

209

1461

N02BF02

ATC

pregabalin; oral

1.5

6.0

201

1395

S01

ICPC

Pain/tenderness of skin

1.6

6.0

139

892

L20

ICD-10 Finland

Atopic dermatitis

1.9

6.0

406

ENC30

NOMESCO Finland

Plastic operation of pharynx

2.2

6.0

202

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1018

2162

5.97

307.65

2.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

450

487

10.28

307.65

1.3

1.1

1.04

1.76

u/ml

0.94

332

240

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

347

39.06

307.65

1.6

1.2

1.77

0.65

u/ml

1.65

252

(3010726) Horse dander IgE Ab [Units/volume] in Serum

368

367

10.94

307.65

1.3

1.0

1.17

1.18

u/ml

0.01

277

155

(3003888) Timothy IgE Ab [Units/volume] in Serum

388

406

10.47

307.65

1.3

1.0

2.92

4.50

u/ml

0.96

285

193

(3005322) IgE [Units/volume] in Serum or Plasma

1318

1629

11.55

307.65

2.1

1.2

397.54

217.68

u/ml

2.76

1295

1478

(3008401) Mugwort IgE Ab [Units/volume] in Serum

364

399

9.93

304.83

1.3

1.0

0.47

1.60

u/ml

1.40

253

150

(3013115) Eosinophils [#/volume] in Blood

2947

18330

3.28

245.43

9.1

6.5

0.34

0.19

e9/l

149.24

2627

15937

(3023430) Cat dander IgE Ab [Units/volume] in Serum

278

314

9.44

226.68

1.2

1.0

3.68

3.40

u/ml

0.09

196

118

(3014133) Dog dander IgE Ab [Units/volume] in Serum

287

340

9.01

225.50

1.2

1.0

3.56

2.31

u/ml

0.64

216

146

(3006315) Basophils [#/volume] in Blood

2842

17819

3.03

223.02

8.7

6.3

0.05

0.04

e9/l

34.01

2505

15252

(3001604) Monocytes [#/volume] in Blood

2835

17762

3.02

222.56

8.7

6.3

0.62

0.59

e9/l

10.82

2500

15196

(3009445) Proteinase 3 Ab [Units/volume] in Serum

582

1424

4.61

220.18

1.7

1.5

13.75

18.11

iu/ml

0.14

(3019198) Lymphocytes [#/volume] in Blood

2856

18186

2.97

213.21

8.8

6.4

1.94

1.91

e9/l

0.39

2565

15944

(3023419) Bacteria identified in Sputum by Culture

266

332

8.51

200.13

3.6

2.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

251

295

9.01

198.16

1.2

1.0

0.13

0.33

u/ml

0.90

159

(3007853) Bacteria identified in Skin by Aerobe culture

1046

4079

3.11

196.37

2.3

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

508

1229

4.59

194.00

1.5

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2982

20047

2.89

189.24

11.0

10.0

4.34

4.08

e9/l

7.15

2620

17325

(3019069) Monocytes/Leukocytes in Blood

2611

16446

2.68

188.33

8.9

6.6

8.63

8.99

10.62

2526

15395

(3006504) Eosinophils/Leukocytes in Blood

2603

16401

2.66

187.10

8.8

6.5

4.66

2.82

97.83

2513

15338

(3022096) Basophils/Leukocytes in Blood

2602

16399

2.66

186.80

8.8

6.6

0.75

0.69

8.35

2513

15329

(3018010) Neutrophils/Leukocytes in Blood

2609

16495

2.66

185.56

8.6

6.4

56.89

57.24

0.85

2551

15726

(3002030) Lymphocytes/Leukocytes in Blood

2629

16841

2.62

179.22

8.9

6.6

26.34

27.75

11.16

2557

15923

(3027135) IgG subclass 1 [Mass/volume] in Serum

234

306

8.06

169.05

1.9

1.3

6.23

6.98

g/l

2.06

194

218

(3024139) IgG subclass 3 [Mass/volume] in Serum

234

306

8.06

169.05

1.9

1.3

0.30

0.42

g/l

5.07

193

218

(3028192) IgG subclass 2 [Mass/volume] in Serum

234

306

8.06

169.05

1.9

1.3

2.97

2.98

g/l

0.04

192

217

(4062490) Immunoglobulin typing, IgG

230

305

7.94

164.16

1.9

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

292

542

5.73

150.89

2.1

1.6

1.33

0.80

g/l

4.85

241

423

(3042936) Bacteria identified in Isolate by Culture

1094

5037

2.61

144.52

2.2

2.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

369

966

4.10

125.43

2.0

1.3

14.21

14.40

iu/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

25.49

114.47

1.3

1.2

32.40

51.90

mg/l

0.92

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

179

287

6.48

107.05

4.7

3.6

—

(3000494) Fungus identified in Specimen by Culture

901

4336

2.39

103.94

1.9

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3240

25907

2.29

93.36

5.9

4.3

12.75

11.96

mm/h

2.45

3107

24245

(3021589) Normoblasts [#/volume] in Blood

2227

15628

1.95

91.23

13.5

11.5

0.00

e9/l

1.25

1765

12793

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

344

1106

3.31

85.34

3.0

2.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

807

3997

2.27

85.29

2.1

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

848

4289

2.24

85.18

2.0

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

610

2720

2.46

81.68

3.1

2.8

10.08

10.78

g/l

4.36

582

2500

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

235

608

4.04

80.56

1.5

1.3

227.50

492.50

titre

1.06

(40768804) Tissue Pathology biopsy report

2035

14321

1.85

77.81

2.3

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1027

5798

2.04

76.42

2.2

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1232

7530

1.92

72.10

1.9

1.7

1.03

1.32

mg/l

2.20

978

5885

(3028026) IgM [Mass/volume] in Serum or Plasma

488

2137

2.46

67.24

2.0

1.9

1.18

1.37

g/l

1.28

459

1955

(3036481) Cortisol [Moles/volume] in Serum or Plasma

642

3191

2.20

65.79

2.8

2.2

295.56

385.21

nmol/l

30.75

604

2960

(3023368) Bacteria identified in Blood by Culture

1488

9920

1.79

64.29

4.8

4.4

—

(44813793) Dust mix specific IgE antibody measurement

106

175

6.19

61.48

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1204

7747

1.79

57.22

6.1

4.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1093

6832

1.82

57.21

1.7

1.5

2.54

2.48

g/l

0.22

713

4217

(4015189) Microbial culture of sputum

11.07

55.52

2.6

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2563

20512

1.69

52.71

3.4

2.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2116

16185

1.65

51.26

6.7

6.8

1.21

mmol/l

0.05

1993

14979

(3018418) pH of Serum or Plasma

1525

10761

1.67

50.47

4.4

4.5

7.40

0.49

1060

7781

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2302

18037

1.65

50.25

7.5

7.6

1.21

mmol/l

0.09

2071

15593

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

247

897

2.87

49.15

2.0

11.21

11.94

mg/l

0.84

233

837

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3190

27338

1.81

48.94

9.7

8.5

76.80

79.38

u/l

2.05

3071

26002

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1498

10614

1.66

48.21

3.4

3.1

1121.85

1392.75

ng/l

1.92

1316

9129

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3757

34169

2.52

47.57

23.1

15.8

23.78

24.86

mg/l

1.30

3380

28053

(3037522) Nuclear Ab [Titer] in Serum

809

4848

1.84

47.37

1.4

1.3

477.24

548.25

titre

0.46

145

1069

(40758558) Short blood count panel - Blood

1513

10791

1.64

47.18

7.2

6.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

758

2.98

46.91

1.4

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

335

1475

2.39

44.97

2.0

1.9

37.22

39.31

u/l

1.06

307

1300

(3013826) Glucose [Moles/volume] in Serum or Plasma

2589

21184

1.62

44.89

5.6

5.1

6.63

6.73

mmol/l

2.03

2487

20129

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

208

730

2.95

44.00

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

191

646

3.05

43.13

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

233

894

2.71

41.69

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

181

609

3.07

41.23

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

181

609

3.07

41.23

1.4

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1042

6943

1.68

41.23

4.3

3.8

330.56

607.58

ng/l

1.01

825

5470

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2342

18914

1.57

41.07

6.8

6.9

10.82

11.86

umol/l

5.56

2239

18079

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

251

1010

2.58

40.82

1.6

1.7

0.24

g/l

0.14

245

960

(3024561) Albumin [Mass/volume] in Serum or Plasma

2055

16129

1.56

40.77

5.4

5.2

35.43

35.69

g/l

1.37

1953

15155

(40768797) Stomach Pathology biopsy report

787

4873

1.76

40.60

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

169

5.12

40.46

1.4

1.7

8.93

9.46

ug/l

0.07

152

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

909

5882

1.70

39.97

1.4

1.3

12.33

11.16

u/ml

0.19

332

2289

(3031040) Bacteria [#/volume] in Urine by Automated count

2713

22748

1.59

39.72

5.1

4.6

307.04

1468.68

e6/l

1.82

314

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.46

39.46

1.1

2.56

2.12

u/ml

0.06

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

960

6334

1.68

39.12

1.4

1.3

28.64

31.48

iu/ml

0.34

293

1940

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

253

1048

2.51

38.71

1.6

1.7

1.22

1.19

g/l

0.90

247

999

(3018095) Leukocytes [#/volume] in Urine

1749

13351

1.55

38.52

4.7

3.9

49.66

96.24

e6/l

3.95

1245

9457

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2018

15993

1.53

36.77

2.8

2.4

77.59

77.95

nmol/l

0.24

1874

14466

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3230

28481

1.68

36.39

26.8

19.6

13.78

13.62

10.09

3212

28096

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

6.52

35.76

1.2

1.1

4.21

7.76

u/ml

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2039

16261

1.52

35.62

3.5

3.0

113.54

138.53

ug/l

6.62

1920

15183

(36304419) Bacteria [Presence] in Urine

1327

9653

1.56

35.51

3.7

3.2

0.00

415.04

estimate

—

(3002582) Erythrocytes [#/volume] in Urine

1560

11764

1.53

35.42

3.9

3.4

83.19

93.59

e6/l

0.14

1185

9001

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

205

808

2.62

34.74

1.2

1.1

3.67

4.01

0.21

116

(3030467) Casts [#/volume] in Urine by Automated count

1370

10139

1.53

33.43

3.8

3.3

0.27

0.42

e6/l

3.99

998

7452

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

215

887

2.50

33.14

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

1266

9239

1.54

32.81

4.3

4.2

91.28

88.81

3.17

1245

9051

(3025159) Blasts/Leukocytes in Blood

527

3079

1.82

32.50

5.1

4.7

0.05

0.21

0.97

133

822

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

207

856

2.50

31.74

1.5

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

2245

18523

1.48

31.49

4.1

3.8

0.00

estimate

1.34

426

3854

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1988

16027

1.48

31.28

2.3

2.1

95.37

96.20

pmol/l

0.34

1085

8542

(3009261) Glucose [Presence] in Urine by Test strip

2277

18863

1.48

31.12

4.2

3.8

0.00

0.10

estimate

0.62

413

3678

(3021440) Promyelocytes/Leukocytes in Blood

521

3071

1.80

31.12

4.9

4.6

0.10

0.12

0.30

142

878

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3035

26687

1.56

30.96

4.7

4.3

14.88

14.76

pmol/l

1.76

2847

24516

(3019550) Sodium [Moles/volume] in Serum or Plasma

3773

35208

2.16

30.89

23.9

18.7

139.72

139.73

mmol/l

0.13

3726

34568

(3035350) Ketones [Presence] in Urine by Test strip

2264

18750

1.47

30.87

4.1

3.8

3.49

5.05

estimate

0.17

432

3947

(3022145) Colonoscopy Study observation

652

4109

1.70

30.74

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

418

3.13

30.71

1.1

3.42

3.27

0.04

(3015736) pH of Urine

1865

14884

1.47

30.68

3.6

3.4

6.24

6.21

0.42

971

8428

(3047007) Chlamydophila sp Ab [Presence] in Serum

132

440

3.07

30.58

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3777

35292

2.16

30.28

24.1

18.9

3.95

3.98

mmol/l

15.99

3728

34587

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

396

2161

1.92

30.16

1.8

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

533

3206

1.76

29.63

4.9

4.5

0.85

0.91

0.19

155

1011

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

131

4.95

29.51

4.8

3.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

50.40

29.36

1.6

2.1

54.97

37.43

umol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1163

8497

1.52

29.29

4.0

3.7

0.13

0.12

—

(3017732) Neutrophils [#/volume] in Blood

700

4552

1.65

29.15

3.0

3.3

5.01

4.65

e9/l

0.33

624

3928

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

6.27

29.13

1.2

1.0

6.08

12.55

u/ml

0.96

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1249

9282

1.50

28.91

2.5

2.3

2.76

2.78

mg/l

0.10

1089

8012

(3002179) Metamyelocytes/Leukocytes in Blood

511

3059

1.77

28.84

4.6

4.4

0.48

0.72

2.32

148

965

(3014599) Egg white IgE Ab [Units/volume] in Serum

134

4.84

28.75

1.0

3.26

0.41

u/ml

0.66

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

123

408

3.08

28.75

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

654

4197

1.67

28.62

6.7

8.3

11.89

12.60

kpa

2.76

627

4038

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

653

4198

1.66

28.36

6.8

8.3

5.04

5.08

kpa

0.67

625

4040

(3003327) Ova and parasites identified in Stool by Light microscopy

245

1149

2.21

28.14

1.8

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

195

833

2.41

27.86

1.3

1.1

—

(3003396) Base excess in Arterial blood by calculation

647

4168

1.66

27.84

6.7

8.2

1.23

0.80

mmol/l

2.18

516

3416

(3019977) pH of Arterial blood

650

4195

1.66

27.76

6.8

8.3

7.42

7.41

1.81

372

2288

(3042631) Mycobacterium sp identified in Specimen

122

412

3.02

27.65

3.5

2.6

—

(3000850) Epithelial cells [#/volume] in Urine

1111

8124

1.51

27.54

2.9

2.7

4.59

5.12

e6/l

0.72

1010

7418

(3022948) Iron [Moles/volume] in Serum or Plasma

883

6149

1.56

27.43

2.5

2.7

35.50

13.15

umol/l

0.48

828

5765

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

167

669

2.56

27.38

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1701

13540

1.44

27.23

4.3

3.7

34.64

91.16

ng/l

1.02

1212

9625

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

144

541

2.72

26.84

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1572

12367

1.45

26.63

3.5

3.6

2.34

2.35

mmol/l

2.69

1454

11250

(44790047) Parainfluenza type 1 nucleic acid detection

121

423

2.92

25.81

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

121

423

2.92

25.81

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

121

423

2.92

25.81

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

834

5803

1.55

25.80

3.5

3.1

1.96

2.35

e6/l

0.79

398

2833

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

896

6343

1.53

25.59

3.4

3.0

0.69

1.02

e6/l

3.59

466

3372

(3014051) Protein [Presence] in Urine by Test strip

1300

9926

1.46

25.54

3.1

2.9

0.05

0.03

0.10

241

(3020874) Milk IgE Ab [Units/volume] in Serum

140

4.48

25.44

1.0

0.57

0.95

u/ml

0.26

(3008536) Aspergillus sp Ab [Presence] in Serum

6.90

25.44

1.4

2.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

828

5772

1.55

25.34

2.4

2.7

2.35

2.28

g/l

3.28

780

5363

(3015076) Soybean IgE Ab [Units/volume] in Serum

117

4.84

25.24

1.0

0.21

3.83

u/ml

0.48

(44806118) Parainfluenza type 4 nucleic acid detection

120

423

2.89

25.22

1.6

1.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3600

33436

1.73

24.71

20.1

15.6

82.01

80.36

ml/min/173m2

6.00

3406

31049

(3016502) Oxygen saturation in Arterial blood

584

3773

1.64

24.61

6.9

8.6

95.52

95.79

0.54

561

3643

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

771

5329

1.55

24.42

2.5

2.8

21.84

23.10

1.80

726

4989

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3465

31895

1.62

24.26

6.0

5.2

1.91

1.92

mu/l

0.19

3279

29512

(3032080) INR in Blood by Coagulation assay

2015

16763

1.41

24.09

15.0

15.2

1.23

1.26

inr

1.63

1702

13976

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1438

11279

1.43

24.08

2.5

2.2

168.88

222.55

u/l

1.88

1365

10683

(3014576) Chloride [Moles/volume] in Serum or Plasma

736

5065

1.55

23.69

6.8

7.5

104.12

104.46

mmol/l

1.12

736

5060

(3048689) Calprotectin [Mass/mass] in Stool

651

4364

1.59

23.48

2.7

2.4

127.77

136.49

ug/g

0.34

547

3486

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1051

7806

1.47

23.43

1.4

1.3

1.57

1.77

u/ml

0.16

256

2092

(3026493) Urate [Moles/volume] in Serum or Plasma

1254

9653

1.43

23.05

2.9

2.8

341.59

345.19

umol/l

0.65

1110

8548

(3021960) Folate [Moles/volume] in Serum or Plasma

1320

10301

1.42

22.32

1.8

1.7

19.71

20.41

nmol/l

1.08

1173

8690

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3848

36659

2.15

22.08

27.0

20.8

77.35

79.12

umol/l

3.18

3820

36271

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

958

7058

1.47

22.05

2.8

3.1

2.46

2.45

mmol/l

0.91

866

6345

(3014111) Lactate [Moles/volume] in Serum or Plasma

515

3312

1.64

21.95

6.9

8.1

1.24

1.34

mmol/l

1.61

502

3247

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

224

3.44

21.60

1.9

2.7

273.74

224.70

e6/l

1.23

199

(46235355) HIV 1 and 2 tests - Meaningful Use set

797

5682

1.50

21.55

1.7

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

297

3.08

21.30

1.2

161.67

164.55

titre

0.01

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1510

12161

1.39

20.87

3.4

3.3

32.14

35.63

u/l

0.82

1438

11498

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

110

412

2.72

20.69

1.5

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

538

3556

1.59

20.41

7.4

9.2

123.65

121.30

g/l

1.82

522

3469

(3000060) B lymphocytes [#/volume] in Blood

5.23

20.30

1.6

2.3

0.24

0.18

e9/l

0.57

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

121

484

2.55

19.96

1.1

1.45

1.54

g/l

1.79

112

442

(1002224) Polysomnography panel

293

1660

1.83

19.67

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

221

3.30

19.23

1.8

2.6

571.15

506.33

e6/l

0.45

185

(3019060) Gas panel - Arterial blood

350

2105

1.73

19.14

3.6

5.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

612

4223

1.53

19.10

2.7

1.73

1.77

0.46

552

3780

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

769

5567

1.47

19.00

1.7

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3146

28774

1.43

18.62

28.3

20.3

330.99

332.64

g/l

20.91

3134

28629

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

262

3.06

18.58

1.8

1.4

29.69

21.00

u/ml

0.63

(36660697) Celiac disease serology panel - Serum

427

2733

1.63

18.41

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

516

3467

1.56

18.11

2.6

2.5

33.89

53.78

u/l

0.80

434

2940

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

135

595

2.31

18.04

1.6

1.7

—

(3026782) Osmolality of Urine

917

6925

1.42

17.93

3.3

2.9

534.98

536.11

mosm/kgh2o

0.06

803

6102

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

270

2.96

17.65

1.7

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3514

32919

1.54

17.64

7.0

6.4

39.90

39.35

mmol/mol

2.51

3339

30849

(3013139) Helicobacter pylori Ag [Presence] in Stool

381

2404

1.65

17.36

1.2

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1400

11391

1.35

17.23

2.8

2.7

56.51

68.38

u/l

0.98

1308

10580

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

165

806

2.09

17.11

1.2

1.3

15.03

5.81

u/ml

—

(3002032) Base excess in Venous blood by calculation

524

3585

1.53

16.89

4.0

3.8

2.09

1.75

mmol/l

1.45

469

3131

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

19.34

16.84

1.7

1.8

1.36

2.80

mg/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

198

1042

1.95

16.70

1.2

31.40

44.78

u/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1955

16758

1.32

16.65

2.9

2.8

—

estimate

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

247

2.99

16.62

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

530

3654

1.52

16.46

4.0

3.8

5.83

5.81

kpa

0.27

516

3556

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

20.11

16.40

1.7

1.8

1.04

0.53

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

20.11

16.40

1.7

1.08

1.78

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

20.11

16.40

1.7

1.8

1.86

1.92

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

20.11

16.40

1.7

1.8

1.51

1.43

mg/l

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

156

760

2.10

16.31

1.3

1.2

25.95

44.86

u/ml

—

(40768443) Skin Pathology biopsy report

271

1590

1.76

16.16

1.3

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3798

36374

1.80

16.11

14.9

12.3

26.54

26.75

u/l

0.30

3726

35383

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

188

987

1.95

15.98

1.3

4.44

7.69

u/ml

0.80

163

(3023420) DNA double strand Ab [Units/volume] in Serum

253

1460

1.78

15.97

1.9

1.8

6.06

7.13

iu/ml

0.29

361

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

210

1145

1.88

15.93

2.2

2.3

0.05

0.01

g/l

0.55

193

1036

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

118

519

2.31

15.88

1.1

8.56

16.55

au/ml

1.71

139

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

187

985

1.94

15.74

1.2

1.3

2.84

5.50

u/ml

0.43

109

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

250

2.91

15.68

1.7

2.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

449

3027

1.54

15.42

3.3

3.0

4.52

4.59

kpa

0.23

435

2941

(3011412) CD3 cells [#/volume] in Blood

332

2.63

15.33

1.8

2.5

1380.82

1140.45

e6/l

1.54

300

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1103

1.88

15.26

2.1

2.3

0.00

g/l

-0.00

182

975

(3012095) Magnesium [Moles/volume] in Serum or Plasma

816

6190

1.40

15.23

3.7

3.5

0.81

0.82

mmol/l

0.38

764

5866

(3026389) Candida sp identified in Specimen by Organism specific culture

101

424

2.42

15.12

1.3

1.4

—

(3012544) pH of Venous blood

533

3741

1.49

15.11

4.0

3.8

7.38

0.04

292

2149

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

414

2755

1.56

15.06

3.4

2.9

134.78

196.81

ng/l

5.12

371

2517

(3023520) Reticulocytes [#/volume] in Blood

476

3269

1.52

14.99

2.7

67.70

68.86

e9/l

0.33

307

2407

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

586

4203

1.46

14.88

3.1

2.8

6.20

8.76

umol/l

4.03

522

3720

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

288

1768

1.68

14.56

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

189

1028

1.88

14.46

2.1

2.3

0.00

g/l

-0.00

181

974

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

6.42

14.09

1.0

1.1

0.06

0.07

u/ml

0.11

(3007461) Platelets [#/volume] in Blood

3867

37369

1.91

14.05

33.3

24.2

262.61

247.50

e9/l

38.84

3817

36661

(3008152) Bicarbonate [Moles/volume] in Arterial blood

343

2222

1.59

13.99

5.4

7.0

24.39

24.43

mmol/l

0.07

327

2118

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3867

37376

1.90

13.93

33.1

24.2

91.29

0.03

3844

37002

(3035941) MCH [Entitic mass]

3867

37376

1.90

13.93

33.1

24.1

30.27

30.42

6.11

3844

37001

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2635

23830

1.31

13.91

3.5

3.3

52.58

50.24

u/l

0.46

2507

22422

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3867

37379

1.90

13.88

33.8

24.7

40.82

40.86

0.06

3843

36989

(3026361) Erythrocytes [#/volume] in Blood

3867

37380

1.90

13.87

33.2

24.2

4.52

4.50

e12/l

2.03

3809

36553

(3010813) Leukocytes [#/volume] in Blood

3867

37383

1.90

13.82

33.3

24.3

7.28

6.68

e9/l

44.54

3808

36552

(3000963) Hemoglobin [Mass/volume] in Blood

3867

37388

1.90

13.74

33.4

24.4

135.74

135.90

g/l

0.27

3846

37019

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

384

2565

1.55

13.70

1.8

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

458

3181

1.50

13.61

2.3

2.8

65.50

66.49

g/l

2.01

428

2933

(3018677) aPTT in Platelet poor plasma by Coagulation assay

746

5677

1.39

13.48

1.9

2.1

29.66

29.71

0.09

730

5536

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

179

3.10

13.45

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3532

33452

1.46

13.42

5.5

5.2

5.92

5.96

mmol/l

0.89

3306

30792

(3013005) Retinol [Moles/volume] in Serum or Plasma

144

3.36

13.39

2.2

1.6

1.92

1.90

umol/l

0.07

131

(3000991) Gas panel - Venous blood

455

3171

1.49

13.29

8.4

9.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

223

1313

1.74

13.15

1.3

1.2

0.45

1.29

u/ml

1.34

105

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

592

4353

1.42

13.03

4.1

4.7

225.05

245.43

u/l

4.88

564

4133

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

362

2.41

12.85

1.5

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

330

2164

1.57

12.77

8.8

10.5

24.80

24.13

mmol/l

3.87

319

2134

(40759836) Histone Ab [Presence] in Serum by Immunoblot

269

2.63

12.66

1.1

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

226

1363

1.70

12.23

2.3

2.4

1.04

0.92

g/l

0.10

206

1178

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

340

2.41

12.20

1.6

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

224

1349

1.70

12.19

2.3

2.4

10.15

10.33

g/l

0.25

210

1213

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

12.41

12.10

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

276

2.56

12.04

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

164

908

1.84

11.91

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

120

3.44

11.91

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

266

2.58

11.89

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

266

2.58

11.89

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

315

2.44

11.78

1.1

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

245

2.64

11.69

1.1

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1577

1.63

11.61

2.3

7.30

7.33

g/l

0.09

240

1450

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

252

2.61

11.58

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

258

2.58

11.57

1.1

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1576

1.63

11.41

2.3

4.07

3.69

g/l

1.08

238

1450

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1577

1.62

11.38

2.3

4.21

4.17

g/l

0.32

239

1451

(3014765) Yersinia sp identified in Stool by Organism specific culture

162

910

1.81

11.25

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1482

1.64

11.18

2.3

2.4

2.94

2.90

g/l

0.38

226

1357

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

12.72

11.12

1.1

1.3

2.28

1.11

iu/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

166

944

1.79

11.07

3.0

3.3

1.58

2.08

index

0.53

484

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

256

1639

1.60

10.97

4.3

5.2

1.52

1.62

1.28

241

1544

(42529406) Shigella sp [Presence] in Stool by Culture

162

919

1.79

10.90

1.2

—

(3035933) Granulocytes/Leukocytes in Blood

138

747

1.88

10.79

3.8

3.4

58.21

57.97

0.08

138

747

(3015235) Bicarbonate [Moles/volume] in Capillary blood

204

1240

1.68

10.75

3.0

2.9

24.70

24.58

mmol/l

0.20

199

1220

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

338

2336

1.49

10.25

3.8

3.6

5.11

5.14

kpa

0.39

325

2238

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

313

2133

1.51

10.16

9.2

10.9

16.42

16.02

1.84

301

2053

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

436

2.11

10.07

1.5

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

112

581

1.95

9.98

1.2

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

285

1914

1.53

9.91

2.9

2.7

0.58

0.62

1.39

285

1902

(3007930) Methemoglobin/Hemoglobin.total in Blood

236

1519

1.59

9.91

4.3

5.4

0.83

0.88

1.24

223

1428

(3004119) Hemoglobin [Mass/volume] in Venous blood

332

2306

1.48

9.82

3.4

3.1

132.45

129.31

g/l

1.84

325

2235

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

232

2.52

9.75

1.2

1.1

20.99

18.07

u/ml

0.27

104

(3002523) Influenza virus A Ag [Presence] in Specimen

111

580

1.94

9.69

1.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

1371

11774

1.25

9.67

2.6

2.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

13.38

9.65

1.1

1.4

0.28

0.18

iu/ml

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

286

1936

1.51

9.59

2.9

2.7

1.18

1.20

0.16

286

1921

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1601

14001

1.24

9.54

4.1

3.8

0.02

0.22

estimate

0.67

362

3175

(3009343) pH of Capillary blood

326

2270

1.47

9.52

3.8

3.6

7.42

7.41

0.99

271

1860

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

289

1966

1.51

9.47

3.7

3.4

1.70

1.83

mmol/l

0.29

218

1444

(37208534) Antinuclear antibody arbitrary concentration in serum

3.46

9.45

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

191

2.64

9.25

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

183

1127

1.65

9.21

1.5

0.11

1.09

iu/ml

0.63

198

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

291

2.29

9.00

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

291

2.29

9.00

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

291

2.29

9.00

1.4

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

206

2.54

8.95

1.6

1.5

5.58

7.22

u/l

1.01

181

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

264

1787

1.51

8.87

4.4

3.9

47.22

47.74

0.13

259

1751

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

6.80

8.82

1.0

78.12

0.22

u/ml

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

232

2.43

8.78

1.7

1.3

437.14

231.18

titre

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3625

34901

1.39

8.78

6.3

5.9

2.69

2.70

mmol/l

0.16

3428

32585

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

264

1798

1.50

8.61

2.5

2.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

199

2.53

8.54

1.1

9.50

9.27

iu/ml

0.02

(3026008) Bacteria identified in Urine by Culture

1210

10364

1.24

8.49

3.3

3.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

20.05

8.46

1.1

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

163

999

1.66

8.39

1.5

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

113

625

1.83

8.34

1.8

1.9

4.75

4.97

mmol/24h

0.33

102

555

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

203

2.48

8.21

1.4

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

298

2112

1.44

7.96

3.3

3.5

4.50

4.47

pmol/l

0.24

268

1894

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.63

7.87

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

226

1523

1.51

7.78

1.8

1.9

1.31

2.41

ug/l

1.18

197

1366

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

132

785

1.70

7.64

1.2

—

(3025941) Bacteria identified in Stool by Culture

262

1827

1.46

7.62

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3571

34416

1.34

7.58

5.4

5.2

4.64

4.62

mmol/l

0.87

3382

32270

(3039162) Centromere protein B Ab [Units/volume] in Serum

423

1.96

7.52

1.3

53.65

52.82

u/ml

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

503

3926

1.32

7.43

1.5

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

227

2.31

7.32

1.5

—

(3019150) Specific gravity of Urine by Refractometry

966

8186

1.24

7.30

4.2

4.0

1.02

1.20

kg/l

0.50

644

5547

(3048929) Epstein Barr virus Ab [Presence] in Serum

160

1013

1.60

7.28

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

773

1.69

7.28

7.3

5.8

259.07

2435.45

iu/ml

0.61

119

(3018001) Oat IgE Ab [Units/volume] in Serum

9.36

7.27

1.1

1.0

6.73

0.19

u/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

233

1607

1.48

7.18

4.2

3.4

25.80

25.16

mmol/l

2.31

226

1548

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

198

2.39

7.17

1.4

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3548

34215

1.31

7.08

5.3

5.1

1.49

1.45

mmol/l

6.82

3351

31876

(3036489) Thrombin time

199

1335

1.52

7.03

1.9

2.0

22.85

21.05

0.78

177

1194

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

167

1078

1.57

7.01

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

194

1296

1.52

6.99

1.6

18.43

16.52

u/ml

0.11

303

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1051

9024

1.22

6.95

2.7

2.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

197

1322

1.52

6.95

1.9

2.3

202.87

639.62

ug/l

2.13

187

1262

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1696

15261

1.19

6.79

1.9

1.33

1.36

mmol/l

0.74

1441

12848

(21494434) Karyotype in Bone marrow

348

2.00

6.78

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

165

1073

1.56

6.72

4.8

6.1

1.23

1.31

mmol/l

0.66

145

945

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3406

32717

1.27

6.70

4.5

4.4

1.27

1.30

mmol/l

1.78

3174

30185

(3030981) Hyaline casts [#/volume] in Urine by Automated count

393

3007

1.34

6.65

2.6

2.5

0.61

0.43

e6/l

0.42

380

2875

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

529

1.80

6.64

1.3

1.2

3.47

5.40

u/ml

0.94

241

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

239

1690

1.44

6.50

1.1

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

144

917

1.59

6.44

1.6

12447.55

12800.08

e6/l

0.02

643

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

118

2.73

6.43

1.5

1.8

0.43

0.77

u/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

351

2654

1.35

6.43

1.4

—

(3022313) Gas panel - Capillary blood

231

1627

1.45

6.42

3.6

3.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

222

1554

1.45

6.37

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

130

812

1.62

6.30

2.8

2.2

132.69

129.18

g/l

0.86

626

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

165

1094

1.53

6.19

2.2

2.5

3.74

3.59

g/l

0.61

159

1043

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

391

3024

1.32

6.15

2.4

2.2

6.45

8.08

ug/l

1.33

353

2704

(3009508) Creatinine [Moles/volume] in Urine

1438

12846

1.19

6.05

3.5

7.54

7.71

mmol/l

0.73

1245

10845

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

156

1029

1.54

6.00

2.1

2.4

193.90

196.02

0.10

149

979

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

360

2764

1.33

5.96

3.5

4.1

89.53

92.75

ng/l

0.26

311

2397

(3008898) HLA-B27 [Presence]

162

1084

1.52

5.85

1.0

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

188

1298

1.47

5.82

2.6

3.7

56.11

56.01

mg/l

0.00

147

1112

(3039000) Anion gap in Blood by calculation

119

746

1.61

5.72

5.1

7.3

11.42

11.30

mmol/l

0.15

106

666

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

187

1296

1.46

5.69

2.6

3.7

32.94

54.90

mg/l

1.65

146

1110

(3018572) Chloride [Moles/volume] in Blood

119

747

1.61

5.69

5.1

7.3

105.36

105.26

mmol/l

0.09

106

667

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.10

5.68

1.0

0.59

0.29

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.85

5.50

1.4

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

217

2.13

5.47

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

129

2.49

5.44

2.3

2.1

1183.43

25130.95

u/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

169

1160

1.48

5.42

2.5

3.5

2.56

3.21

ratio

0.37

670

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

533

1.70

5.40

1.3

1.2

2.71

3.79

u/ml

0.54

191

(4094501) Cardiovascular stress test using bicycle ergometer

160

1087

1.49

5.40

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

303

2306

1.34

5.34

1.4

1.3

49.39

56.53

au/ml

0.22

175

(3003458) Phosphate [Moles/volume] in Serum or Plasma

594

4927

1.24

5.34

5.6

6.4

1.03

mmol/l

0.14

561

4603

(3016650) Hepatitis A virus Ab [Presence] in Serum

590

1.66

5.28

1.1

—

(1616796) Gas panel - Central venous blood

121

778

1.57

5.26

4.4

3.8

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.92

5.21

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

126

2.47

5.19

1.1

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

496

1.71

5.12

1.2

1.1

—

8.18

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

324

2507

1.32

5.10

2.5

2.4

22.87

21.31

au/ml

0.09

269

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

445

3591

1.27

5.08

2.2

2.3

0.21

g/l

0.52

420

3365

(3034770) Mitochondria Ab [Titer] in Serum

152

1038

1.48

5.02

1.2

1262.22

1108.85

titre

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

595

4968

1.23

5.02

1.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

159

1099

1.47

4.95

2.1

94.80

91.99

0.94

153

1063

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1203

10732

1.17

4.92

4.7

4.4

21.21

22.07

1.14

574

5258

(3045142) Bone marrow Pathology biopsy report

452

1.72

4.81

1.4

—

(3037756) Immunofixation for Serum or Plasma

119

780

1.54

4.79

1.4

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

196

2.10

4.76

2.0

2.1

8.70

8.37

mmol/l

0.19

196

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

272

1.92

4.72

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

430

3488

1.26

4.70

2.5

2.3

13.77

13.49

nmol/l

0.32

385

3168

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

224

2.02

4.70

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

171

2.17

4.68

1.5

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

171

2.17

4.68

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

171

2.17

4.68

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

171

2.17

4.68

1.5

1.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

4.30

4.62

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1119

9969

1.17

4.61

3.6

3.3

0.01

0.13

estimate

0.78

351

3000

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

261

1.93

4.58

1.5

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

156

1093

1.44

4.55

1.4

271.98

272.40

ug/g

0.01

636

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

227

1.99

4.54

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1349

12204

1.16

4.53

3.6

3.5

45.51

49.92

mg/l

0.28

859

7836

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

396

3200

1.26

4.48

1.6

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

394

1.74

4.48

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

617

1.59

4.47

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

112

2.42

4.38

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

341

2715

1.28

4.36

1.9

2.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.21

4.33

1.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.21

4.33

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.21

4.33

1.4

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

310

1.82

4.31

1.8

1.5

—

(3012501) Base excess in Blood by calculation

110

728

1.53

4.28

4.2

4.3

2.26

2.58

mmol/l

0.67

487

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

370

2983

1.26

4.28

2.0

2.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

366

2948

1.27

4.26

2.7

72.14

66.61

ml/min/173m2

2.07

148

1242

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

187

1370

1.38

4.26

2.1

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

172

1243

1.40

4.25

1.8

1.7

6.68

3.94

mg/l

1.28

145

912

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

129

885

1.47

4.22

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

103

675

1.54

4.19

1.1

1.2

245.39

277.68

u/ml

0.53

416

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

292

1.83

4.15

1.1

1.2

100.68

108.46

pmol/l

0.77

292

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

646

1.55

4.12

1.2

1.4

154.94

155.61

au/ml

0.02

192

(3007566) Smooth muscle Ab [Titer] in Serum

148

1049

1.43

4.09

1.2

90.00

101.38

titre

0.22

(3035637) Corticotropin [Mass/volume] in Plasma

428

1.67

4.08

1.4

1.6

28.27

27.33

ng/l

0.06

428

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

108

721

1.51

4.05

1.2

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

673

1.53

4.04

1.9

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

109

730

1.51

4.03

1.1

1.2

—

106.05

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

123

2.29

4.03

1.6

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

123

2.29

4.03

1.6

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1461

13381

1.14

4.01

5.7

5.5

3.04

3.11

ug/l

0.03

1340

12169

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

217

1.95

4.00

2.5

2.9

37.86

40.19

0.36

116

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

176

2.05

3.99

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

176

2.05

3.99

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

138

972

1.43

3.96

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

124

2.27

3.96

1.6

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

327

1.75

3.93

2.5

3.3

14.83

12.12

index

0.54

194

(3002619) Bacteria identified in Specimen by Culture

2.64

3.89

1.4

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

7.29

3.85

1.1

—

(4195642) Thrombophilia screening test

492

1.60

3.78

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

175

2.01

3.68

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

182

1.99

3.67

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

103

2.34

3.66

1.0

1.2

—

(4268621) Lupus anticoagulant assay

381

1.66

3.62

2.5

2.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1354

12407

1.14

3.60

4.4

4.2

7.83

8.83

mg/mmol

0.36

848

7799

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.51

3.60

1.6

1.9

—

(3004809) Band form neutrophils/Leukocytes in Blood

628

1.51

3.56

2.9

3.8

1.26

1.49

0.29

560

(3029937) Albumin [Presence] in Urine by Test strip

1139

10325

1.14

3.56

4.5

4.0

0.00

estimate

1.98

402

3525

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

144

2.09

3.52

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

122

861

1.43

3.51

1.2

2.1

—

(3017569) Oxygen content in Arterial blood

200

1.91

3.47

2.4

2.3

16.09

16.25

0.10

200

(21491868) Cryoglobulin [Mass/volume] in Serum

125

2.17

3.47

1.1

1.3

—

0.26

g/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

898

8023

1.15

3.44

3.4

3.2

0.65

0.78

ug/l

5.55

591

5247

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

387

1.64

3.43

1.1

94.72

96.37

0.18

363

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

603

1.50

3.38

3.4

2.8

3110.83

1574.55

u/ml

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

227

1777

1.29

3.37

1.5

1.7

1.71

1.52

g/l

2.20

197

1534

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

492

1.56

3.34

1.1

121.97

114.17

1.91

448

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

168

1264

1.34

3.31

2.0

1.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

106

738

1.45

3.30

1.5

3.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

412

3464

1.21

3.27

6.5

8.0

9.72

10.08

mmol/l

0.47

389

3333

(3002256) Pathology report gross observation

570

4943

1.18

3.20

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

288

1.71

3.17

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

389

1.60

3.13

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

166

1259

1.33

3.12

4.0

3.7

24.95

24.84

mmol/l

0.23

157

1159

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

118

2.13

3.09

1.4

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.67

3.08

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

678

5980

1.16

3.08

1.9

1.7

1109.56

1148.87

nmol/l

0.58

520

4541

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

5.84

3.02

1.0

0.02

0.31

u/ml

—

(3017354) Segmented neutrophils/Leukocytes in Blood

401

1.58

3.01

2.4

3.9

54.16

57.61

0.69

344

(3027456) Digoxin [Moles/volume] in Serum or Plasma

653

1.45

2.99

3.7

3.3

0.78

0.80

nmol/l

0.13

530

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.85

2.97

1.1

1.0

169.60

89.85

titre

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.55

2.95

2.8

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.83

2.91

1.3

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

146

1101

1.34

2.88

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.10

2.88

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.10

2.88

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.71

2.87

1.3

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

171

1322

1.31

2.84

1.9

2.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

392

1.56

2.82

1.5

1.3

1.27

1.47

nmol/l

0.71

355

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

331

1.61

2.77

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

139

1048

1.34

2.76

1.3

—

(4024509) Urine culture

206

1639

1.27

2.75

2.0

1.9

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.01

2.72

1.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

559

1.46

2.70

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

197

1.78

2.67

1.3

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

189

1496

1.28

2.64

1.6

1.8

0.28

0.33

mg/l

0.50

708

(3009214) Lutropin [Units/volume] in Serum or Plasma

123

917

1.35

2.64

1.5

1.4

10.90

9.54

u/l

0.46

104

745

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.13

2.64

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.39

2.63

1.0

31.64

38.29

iu/ml

0.14

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

274

2265

1.23

2.62

1.2

113.00

142.51

u/ml

0.80

828

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

108

790

1.38

2.62

1.9

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

440

1.51

2.62

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

523

1.46

2.59

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

115

852

1.36

2.58

1.5

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

346

1.57

2.56

3.3

4.6

—

(3045414) Leukocytes [Presence] in Urine

406

3496

1.18

2.51

2.1

0.02

0.01

estimate

0.20

705

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

340

1.57

2.51

5.5

23.68

62.36

u/ml

1.07

(3023410) Appearance of Cerebral spinal fluid

372

1.54

2.50

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

2.32

2.48

1.4

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

4.38

2.47

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

136

1041

1.32

2.47

1.9

1.7

339.58

293.30

mu/l

0.63

125

955

(3028707) Methadone [Presence] in Urine by Screen method

456

1.48

2.43

1.3

2.9

—

(3024928) Oxygen saturation in Venous blood

126

959

1.32

2.39

2.6

2.9

64.34

61.95

0.54

121

939

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

160

1.82

2.39

1.0

1.6

2.25

2.07

u/field

0.10

112

(3027008) Opiates [Presence] in Urine

144

1117

1.30

2.38

1.3

2.1

—

(3027944) Amphetamines [Presence] in Urine

142

1100

1.30

2.38

1.3

2.0

—

(4035726) Immunohistochemistry procedure

380

3272

1.18

2.37

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

197

1593

1.25

2.34

2.1

2.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

130

998

1.31

2.33

2.1

1.9

197.48

207.51

pmol/l

0.67

124

945

(3028300) Cannabinoids [Presence] in Urine

144

1123

1.29

2.30

1.3

2.1

—

(3016879) Cocaine [Presence] in Urine

133

1028

1.30

2.28

1.3

2.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.48

2.27

1.0

10.4

—

(3033099) Centromere Ab [Titer] in Serum

2.16

2.24

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

142

1111

1.29

2.23

1.3

2.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.11

2.22

1.0

1.1

0.02

u/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

172

1.75

2.20

1.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

480

4234

1.15

2.20

1.6

1.8

1.42

1.49

1.36

411

3725

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

112

850

1.33

2.19

1.4

271.15

1039.23

e6/l

1.76

674

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.34

2.18

1.1

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

129

1.87

2.16

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

370

1.49

2.15

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.00

2.14

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

204

1.67

2.14

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

110

837

1.32

2.13

1.3

43.55

30.69

e6/l

0.15

618

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.10

2.12

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

2.05

2.11

1.3

38.93

31.45

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

177

1434

1.25

2.10

1.4

26.63

28.80

iu/l

0.40

145

1247

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

124

965

1.29

2.05

1.3

593.86

557.72

mg/l

0.20

116

921

(3038177) Helicobacter pylori Ab [Presence] in Serum

558

1.39

2.04

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.18

2.04

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

159

1278

1.25

2.03

2.1

1.9

41.49

41.98

nmol/l

0.11

152

1239

(3028679) Herpes simplex virus Ab [Presence] in Serum

177

1.70

2.02

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

194

1.65

1.96

1.2

0.52

0.56

ratio

0.46

108

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.03

1.95

1.6

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.97

1.93

1.1

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

157

1.72

1.92

1.1

693.43

359.35

ng/l

—

(3017704) Immunofixation for Urine

211

1.62

1.91

1.3

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.92

1.90

1.6

8.96

9.17

ug/l

0.10

(3011985) Renin [Units/volume] in Plasma

515

1.39

1.90

1.6

1.4

40.13

66.06

mu/l

0.90

455

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

109

845

1.30

1.88

1.2

3.85

3.76

mmol/l

0.27

101

799

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

324

1.49

1.88

1.1

—

(3024263) Appearance of Synovial fluid

181

1.66

1.88

1.6

1.7

—

(3045788) Cell count panel - Pleural fluid

374

1.45

1.86

1.5

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

168

1.67

1.80

1.3

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.09

1.75

1.5

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.67

1.72

1.1

1.3

5.81

5.95

mmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

417

3714

1.14

1.70

3.7

3.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

441

3945

1.13

1.68

4.0

4.4

39.41

24.49

ug/l

0.23

373

3201

(3028717) Thiamine [Mass/volume] in Blood

2.19

1.67

1.0

1.3

58.92

68.96

ug/l

1.01

(3046861) Legionella sp Ag [Presence] in Urine

3.16

1.66

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

120

960

1.26

1.65

1.9

2.1

4.59

4.04

iu/l

0.24

396

(3006571) Granulocytes/Leukocytes in Synovial fluid

401

1.40

1.65

1.6

54.31

58.57

0.28

256

(3022621) pH of Urine by Test strip

323

2834

1.15

1.65

2.7

2.6

6.05

6.06

0.06

226

1909

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.98

1.64

1.2

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

453

1.37

1.63

1.5

1.4

3218.49

3711.46

e6/l

0.09

319

(3022806) Fractional oxyhemoglobin in Capillary blood

436

1.38

1.63

2.2

1.8

90.31

89.84

0.36

431

(42529582) MDA5 Ab [Presence] in Serum by Line blot

105

1.81

1.62

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

105

1.81

1.62

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

105

1.81

1.62

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

105

1.81

1.62

1.2

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

344

1.43

1.61

1.3

1.4

207158.96

110707.22

e6/l

0.20

246

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

262

1.49

1.60

1.2

1.3

15.18

12.07

u/l

0.84

244

(3040151) Glucose [Moles/volume] in Capillary blood

380

1.40

1.56

3.9

5.6

7.27

7.19

mmol/l

0.08

323

(3012565) Volume of 24 hour Urine

168

1.61

1.54

1.7

2.5

2080.00

1919.54

0.33

151

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.03

1.54

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.34

1.52

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

218

1.52

1.48

1.2

120.46

84.20

u/l

0.70

179

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

211

1.52

1.45

1.3

1.2

18.17

19.82

u/l

0.13

169

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

169

1425

1.19

1.44

3.2

3.5

16411.30

3256.84

u/ml

0.44

142

1232

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

3.02

4.81

u/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

228

1.50

1.43

1.5

1.6

86.06

84.71

umol/l

0.09

228

(40768795) Lymph node Pathology biopsy report

363

1.38

1.40

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

374

0.64

1.39

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

222

1.49

1.38

7.7

7.1

15.28

160.92

ug/l

0.86

146

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

1.38

1.4

1.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.61

1.36

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

548

1.30

1.35

1.9

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.32

0.0

1.2

—

(3035880) pH of Pleural fluid

208

1.49

1.32

1.4

7.39

7.40

0.04

146

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.74

1.30

1.1

1.4

107.25

84.85

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

177

1.53

1.28

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.09

1.27

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

790

7399

1.08

1.26

1.8

1.7

42793232.25

29276638.22

pmol/l

0.22

666

6162

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

449

1.32

1.25

1.3

0.17

0.22

nmol/l

0.63

366

(3045424) Erythrocytes [Presence] in Urine

207

1804

1.16

1.22

2.0

2.2

0.02

0.47

estimate

0.49

541

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.63

1.21

2.2

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

101

1.69

1.19

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.83

1.19

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

427

1.32

1.19

1.5

1.29

0.03

307

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.31

1.18

1.3

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.88

1.18

1.8

1.9

15.27

17.48

umol/l

0.37

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

428

1.31

1.17

2.5

2.2

18.08

22.74

mg/l

0.36

154

(21494890) Protein electrophoresis panel - 24 hour Urine

385

1.33

1.16

1.3

2.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

315

2834

1.12

1.16

3.7

4.3

1.22

1.23

mmol/l

0.52

282

2462

(3003434) Protein [Mass/volume] in Pleural fluid

517

1.28

1.16

1.4

1.5

34.49

32.74

g/l

0.50

464

(3004451) EKG impression Narrative

215

1.45

1.15

1.4

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

291

1.38

1.15

1.3

1.4

169.18

200.78

pmol/l

0.44

291

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.64

1.15

2.3

2.5

10.33

10.06

kpa

0.13

110

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.64

1.15

2.3

2.5

4.99

4.91

kpa

0.10

110

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

150

1.54

1.14

1.2

2.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

241

1.41

1.13

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.85

1.13

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

475

1.29

1.12

1.5

1.3

1937.58

284.14

pmol/l

0.50

408

(3041354) Potassium [Moles/volume] in Venous blood

388

1.32

1.11

3.4

2.4

4.09

mmol/l

0.02

381

(3035285) Chloride [Moles/volume] in Venous blood

388

1.32

1.11

3.4

2.4

105.69

105.59

mmol/l

0.06

381

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

151

1.53

1.11

1.4

1.8

82.46

121.59

umol/l

0.54

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

144

1.53

1.08

1.0

1.1

134.05

194.69

iu/ml

1.32

144

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

120

1.59

1.08

2.4

2.2

0.97

1.14

ug/l

0.19

110

(3006653) Thiamine [Moles/volume] in Blood

185

1.46

1.08

1.1

1.2

139.79

135.53

nmol/l

0.24

185

(3043238) Trisomy 21 risk [Likelihood] in Fetus

443

1.29

1.08

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.76

1.06

1.6

1.5

1.19

1.18

mmol/l

0.26

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

410

1.30

1.04

1.4

1.3

22.55

27.81

u/l

0.57

333

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

141

1211

1.17

1.04

2.6

3.2

0.38

0.34

iu/ml

0.63

651

(3047352) Trisomy 18 risk [Likelihood] in Fetus

437

1.29

1.03

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

393

1.30

1.03

1.0

1.1

—

5.15

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.27

1.03

5.0

7.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.27

1.03

1.0

2.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.64

1.03

1.1

1.2

90.43

85.44

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

341

1.32

1.03

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.06

1.02

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

432

1.28

0.98

1.2

1.3

7.57

7.31

mmol/l

0.25

377

(40762887) Creatinine [Moles/volume] in Blood

2.18

0.98

1.2

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

181

1.44

0.98

3.6

3.1

21.88

24.07

mu/l

0.11

175

(3035320) C reactive protein [Mass/volume] in Body fluid

266

1.36

0.97

2.8

2.7

23.35

30.12

mg/l

0.77

187

(3037121) Protein [Mass/volume] in Urine

146

1266

1.16

0.97

3.1

326.81

391.20

mg/l

0.24

558

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

241

1.37

0.96

1.8

—

(3000012) Reticulocyte production index

523

1.25

0.96

2.0

2.3

0.93

0.89

0.33

362

(3034274) Bile acid [Moles/volume] in Serum --fasting

311

1.32

0.94

2.4

1.8

6.76

8.01

umol/l

0.21

222

(3028308) Erythrocytes [#/volume] in Pleural fluid

408

1.28

0.94

1.4

49148.38

81467.62

e6/l

0.55

237

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

116

0.52

0.94

1.2

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

260

1.35

0.93

1.0

1.1

246.04

293.60

mg/l

0.77

225

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

374

1.29

0.92

1.2

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.14

0.91

1.0

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

270

1.34

0.90

1.2

44.74

43.42

mg/l

0.04

222

(3041806) Other cells [#/volume] in Blood by Manual count

1.75

0.90

1.4

1.5

0.71

0.48

e9/l

1.04

(3000330) Specific gravity of Urine by Test strip

199

1779

1.12

0.87

3.9

3.2

1.02

ratio

1.81

181

1614

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.86

0.87

2.0

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

272

1.33

0.87

1.9

2.0

1.30

1.63

u/field

0.31

144

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

369

1.28

0.86

1.2

57.05

66.22

u/l

0.71

321

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

273

1.32

0.85

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

379

1.27

0.85

3.5

2.4

1.19

1.20

mmol/l

0.50

372

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

342

0.73

0.82

1.3

1.5

55.81

58.07

ug/l

0.14

342

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

113

1.51

0.82

2.0

143.06

177.30

1.26

107

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.88

0.81

1.0

1.3

5.83

21.00

u/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

288

2644

1.10

0.79

1.6

1.8

—

(3044007) Cell count panel - Peritoneal fluid

124

0.56

0.77

1.4

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

466

1.23

0.77

1.1

—

(3034426) Prothrombin time (PT)

115

1.48

0.76

1.1

1.2

28.88

29.24

0.08

115

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.77

0.76

2.8

2.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.77

0.76

1.3

1.5

—

(3003181) Sodium [Moles/volume] in Urine

659

1.19

0.76

1.3

72.55

61.98

mmol/l

1.39

532

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

132

1.44

0.75

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

183

1.37

0.75

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

716

1.18

0.74

5.0

3.4

22.99

28.25

mg/l

0.69

477

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

587

1.20

0.74

1.1

23.00

1104.88

iu/ml

—

119

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

227

1.32

0.74

1.1

7.43

8.86

nmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.84

0.73

4.4

1.1

—

(3025130) Human papilloma virus identified in Specimen

451

1.22

0.73

1.7

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

150

1.40

0.73

1.1

1.3

161.81

168.29

mmol/24h

0.13

150

(3027923) C peptide [Moles/volume] in Serum or Plasma

219

1.33

0.73

1.3

1.4

1.27

1.25

nmol/l

0.04

153

(4146454) Self-monitoring of blood glucose

411

0.78

0.71

2.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

444

1.22

0.71

1.1

1.49

3.63

eliau/ml

2.30

195

(3034092) Cytoplasmic Ig cells/cells in Blood

1.71

0.70

8.6

9.6

0.37

0.21

—

(3001019) Free T4 and TSH panel - Serum or Plasma

179

1619

1.11

0.68

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

120

0.58

0.67

1.7

1.4

12.91

11.78

g/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

203

0.69

0.67

28.5

15.0

875.72

7188.46

nmol/l

0.49

196

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

179

1.34

0.66

1.1

1460.00

1498.08

miu/ml

0.07

179

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

1.59

0.65

1.7

1.3

67.20

77.27

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

470

0.81

0.63

1.6

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

138

1.38

0.62

1.1

103.93

93.14

0.74

106

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

102

0.59

0.62

5.8

7.6

5.90

5.98

kpa

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.63

0.62

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

343

1.23

0.61

2.7

2.8

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.5

—

32.83

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

555

1.17

0.60

1.6

1.5

55.86

60.29

ug/l

0.43

469

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.60

0.0

1.0

—

79.33

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

444

0.81

0.59

1.6

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

400

0.80

0.59

1.7

1.8

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.50

0.59

1.2

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

326

1.23

0.59

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.54

0.59

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

436

1.20

0.59

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

465

0.82

0.59

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

110

979

1.13

0.58

1.3

189.85

213.50

miu/ml

0.28

429

(3036071) Salmonella sp Ab [Titer] in Serum

106

1.42

0.57

1.2

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.48

0.57

1.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

474

0.82

0.57

1.6

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

172

0.70

0.56

1.0

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

185

1.30

0.56

1.1

1.05

1.06

ratio

0.15

145

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

311

1.22

0.55

1.1

290.66

287.94

mg/l

0.08

286

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

424

4470

0.94

0.55

4.9

5.0

32.41

32.29

0.08

299

2978

(40765096) Chromosome analysis panel by Banding

133

1.35

0.55

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

182

0.71

0.54

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

240

1.25

0.53

1.6

1.9

6.80

6.89

mmol/l

0.06

161

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.45

0.53

1.8

1.5

117.55

142.49

ug/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.43

0.53

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

508

1.16

0.51

5.8

6.4

11.55

12.01

mg/l

0.43

478

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.41

0.50

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.50

1.5

1.2

—

(3014271) Vancomycin [Susceptibility]

156

0.70

0.49

2.8

2.7

—

(21494755) Public health laboratory ask at order entry panel

328

3098

1.06

0.49

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

511

1.16

0.49

1.5

—

(3024471) HLA-A [Type]

109

0.64

0.48

1.0

—

(3014891) Appearance of Pleural fluid

1.52

0.48

1.4

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.47

0.47

1.5

1.3

0.23

3.00

mmol/l

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

430

1.16

0.46

1.2

1.4

—

nmol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.43

0.46

4.7

3.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

855

1.11

0.45

2.3

113.01

104.48

ug/min

0.09

509

(3016018) Differential panel - Cerebral spinal fluid

431

1.16

0.45

1.5

1.3

—

(3016038) Potassium [Moles/volume] in Urine

242

0.78

0.44

1.1

39.19

34.44

mmol/l

0.42

215

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

386

1.17

0.43

2.4

20.93

36.71

iu/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

447

0.85

0.43

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

447

0.85

0.43

1.6

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.64

0.42

5.8

7.8

7.67

5.38

kpa

—

(21494814) CD8 cells/Lymphocytes in Specimen

149

1.28

0.41

1.6

2.0

31.00

31.23

0.02

149

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.2

—

410.20

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.0

—

0.22

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

116

1265

0.91

0.41

1.2

1.52

1.53

g/l

0.17

116

1265

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

520

1.14

0.41

1.5

0.96

0.97

ratio

0.09

320

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

520

1.14

0.41

1.5

1.02

1.16

ratio

0.73

320

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

520

1.14

0.41

1.5

1.07

1.21

ratio

0.75

321

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.1

—

0.02

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.43

0.39

1.0

12.88

7.79

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

843

0.90

0.38

2.8

3.7

254.36

765.33

u/ml

0.76

782

(3005532) Lymphocytes/Leukocytes in Pleural fluid

133

1.28

0.38

1.2

1.6

49.50

62.55

0.72

110

(40768446) Kidney Pathology biopsy report

151

1.26

0.38

1.4

1.6

—

(4034850) Laboratory test

114

1049

1.09

0.37

10.3

9.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.33

0.37

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

450

0.87

0.36

1.6

1.5

0.26

0.31

nmol/l

0.59

347

(3023183) Ammonium ion [Moles/volume] in Plasma

850

0.90

0.36

2.4

2.9

29.17

36.04

umol/l

1.96

773

(40768441) Liver Pathology biopsy report

289

0.83

0.36

1.5

—

(4133840) Spirometry

1.36

0.36

1.4

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.43

0.35

1.2

1.1

—

(44806071) Cardiolipin IgM antibody measurement

1.43

0.35

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

181

1.22

0.34

1.4

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.34

0.34

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.33

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

109

1.29

0.33

1.3

1.6

63.14

406.39

nmol/24h

0.73

109

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.30

0.33

1.2

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

488

4721

1.04

0.32

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

143

0.77

0.32

1.6

1.2

2.50

4.73

umol/l

2.59

123

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

119

1.26

0.31

1.7

2.0

1.31

1.59

ratio

0.59

112

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

120

1.25

0.30

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

410

1.12

0.29

1.2

1.3

—

(3024932) HLA-DR beta [Type]

107

0.75

0.29

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

121

0.74

0.27

2.0

4.7

—

(3049717) Cytology report of Urine Cyto stain

156

1479

1.06

0.26

2.5

2.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

278

0.86

0.26

1.0

1.6

13.90

13.14

umol/l

0.19

257

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.68

0.26

7.6

5.9

8.80

8.49

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.68

0.26

3.8

3.0

47.60

46.38

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

396

3840

1.03

0.25

2.1

2.0

3.42

3.52

ratio

0.86

319

3024

(3032773) Endomysium IgG Ab [Titer] in Serum

320

1.13

0.25

1.2

1.1

—

(3016228) CD19 cells/cells in Blood

151

1.19

0.25

1.6

2.0

5.11

8.72

1.72

144

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

431

4191

1.03

0.24

7.8

6.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

962

0.93

0.24

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.71

0.24

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

112

1187

0.94

0.23

1.2

1.1

0.52

0.63

ratio

1.57

164

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

114

1076

1.06

0.23

1.6

1.4

—

(40768793) Breast Pathology biopsy report

806

0.93

0.23

1.2

1.4

—

(3044927) Protein electrophoresis panel - Urine

370

1.11

0.23

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

106

1.23

0.23

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

1385

13679

1.02

0.22

3.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.22

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.22

0.22

2.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

163

1.17

0.21

4.3

3.6

0.84

1.16

0.52

163

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

5.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

391.00

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

156

0.83

0.21

1.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

156

0.83

0.21

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

42.61

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

277

1.12

0.21

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.16

0.21

3.2

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

230

0.87

0.21

2.3

2.2

2.21

3.05

ug/l

0.68

210

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

30.00

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

449

0.91

0.20

1.4

1.6

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.20

0.0

1.1

—

8.56

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.22

0.20

1.0

2.2

—

(3000034) Microalbumin [Mass/volume] in Urine

307

1.11

0.20

3.8

3.0

36.95

47.61

mg/l

0.13

236

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.18

0.19

1.5

1.2

—

(3004775) Volume in Urine collected for unspecified duration

279

1.11

0.19

2.5

2.2

727.24

626.44

0.66

187

(3003694) ABO and Rh group [Type] in Blood

1009

10226

0.98

0.19

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.13

0.18

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

853

1.06

0.18

2.0

2.1

6165.27

5200.06

u/l

0.11

341

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

121

0.83

0.18

1.2

—

16.07

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

329

1.10

0.17

1.7

1.6

352.17

324.80

mu/l

0.13

265

(3020876) Protein [Mass/time] in 24 hour Urine

455

1.08

0.17

2.0

2.4

1.35

1.28

g/24h

0.05

263

(3019225) pH of Specimen

360

3516

1.03

0.17

3.9

4.4

7.34

7.35

0.37

273

2541

(3003329) Lymphocytes/Leukocytes in Synovial fluid

320

1.09

0.17

1.7

1.5

36.24

29.92

0.35

199

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

205

1.12

0.17

1.1

1.23

1.14

u/l

0.20

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

205

1.12

0.17

1.3

1.7

—

(3012441) Differential panel - Pleural fluid

388

1.08

0.16

1.4

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.76

0.15

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

108

1127

0.96

0.15

3.5

2.9

1.45

1.58

mg/l

1.11

102

1042

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

1.16

0.15

1.1

—

(3020650) Glucose [Presence] in Urine

129

0.85

0.14

2.0

1.8

0.00

0.05

estimate

0.80

129

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

223

0.90

0.14

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.78

0.14

1.1

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.19

0.14

3.7

2.5

5.20

411.27

ug/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

947

0.96

0.12

1.5

1.6

923.30

1030.95

mu/l

0.40

788

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.18

0.12

3.1

1.5

—

0.23

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

228

0.92

0.10

1.2

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

1.13

0.09

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.09

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

165

0.91

0.08

1.2

13.00

9.76

mm/h

0.51

165

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.05

0.08

3.8

6.2

—

884.80

—

(3051101) Glucose [Moles/volume] in Cord blood

1.09

0.08

7.3

6.9

8.86

8.23

mmol/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.08

0.07

2.0

1.2

—

133.40

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

225

0.93

0.07

1.3

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.85

0.06

1.6

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

1.09

0.06

1.1

—

(40768806) Pleura Pathology biopsy report

394

1.04

0.06

1.3

1.6

—

(3006462) Nitrate [Presence] in Urine

158

1.08

0.06

2.6

3.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

623

1.03

0.05

1.3

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

159

1.07

0.05

1.8

1.7

38.61

40.11

g/l

0.47

159

(3047189) Immunofixation for 24 hour Urine

191

0.94

0.04

1.3

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

805

0.98

0.04

1.7

1.6

—

(3006270) Folate [Moles/volume] in Blood

281

0.96

0.04

1.0

1.2

382.50

366.31

nmol/l

0.19

245

(40761536) Microorganisms panel - Urine sediment

284

2818

1.01

0.03

4.7

3.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

149

0.94

0.03

2.7

2.9

0.67

0.61

mmol/l

2.50

149

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

732

0.98

0.03

1.5

83.53

185.96

pmol/l

2.87

718

(3006576) Bicarbonate [Moles/volume] in Blood

112

1.07

0.03

3.2

7.2

24.03

24.80

mmol/l

0.29

103

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

550

1.02

0.02

2.3

2.8

9.70

606.75

u/ml

0.69

540

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

172

1.05

0.02

1.0

1.4

—

1631921.29

—

(44806420) Estimation of glomerular filtration rate

389

0.98

0.02

2.1

2.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

292

1.03

0.02

1.0

298.52

315.79

ng/l

0.17

207

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

292

1.03

0.02

1.0

859.14

711.92

ng/l

0.57

200

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

183

1.04

0.01

1.1

1.2

—

70.77

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

233

1.03

0.01

1.2

2.0

72.43

117.39

ng/l

2.27

233

(3008295) Osmolality of Serum or Plasma

413

1.02

0.01

1.2

1.3

279.32

278.34

mosm/kgh2o

0.11

320

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

281

2804

1.00

0.00

1.8

3.33

3.48

mmol/l

1.27

199

1991

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

1.05

0.00

1.2

—

940.91

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

295

1.02

0.00

1.0

38.52

42.15

ng/l

0.22

205

(40768800) Prostate Pathology biopsy report

855

0.99

0.00

1.1

1.2

—

(4198724) Urine methamphetamine measurement

121

0.99

0.00

1.2

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

259

1.00

0.00

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

174

0.98

0.00

1.8

2.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

366

1.01

0.00

1.2

—

43.67

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

767

1.00

0.00

2.2

1.9

1.05

0.86

nmol/l

1.28

650

(3043410) Blood group antigens tested for on Red Blood Cells

1.03

0.00

1.1

1.8

—

(4211845) Urine protein measurement

177

1.02

0.00

2.6

3.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.86

0.00

9.2

12.9

5.58

5.86

mmol/l

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.86

0.00

1.4

2.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.5

—

0.26

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.85

-0.00

1.4

2.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.36

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.90

-0.00

2.3

1.9

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3048879) Bone marrow aspiration report

0.94

-0.00

1.8

1.9

—

2.00

—

(1761482) Bacteria [#/volume] in Urine by Culture

810

1.00

-0.00

5.1

4.0

—

(40758292) HTLV I+II Ab panel - Serum

1.00

-0.00

1.1

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_EOSINOPHIL_SUGG and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_EOSINOPHIL_SUGG	0.961 [0.87, 1.07]	0.46
Birth year	0.995 [0.99, 1.0]	0.228

During the follow-up period (1.1.1998 — 31.12.2019), 715 out of 6298 females with ASTHMA_EOSINOPHIL_SUGG died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_EOSINOPHIL_SUGG	0.787 [0.72, 0.86]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.077

During the follow-up period (1.1.1998 — 31.12.2019), 1120 out of 7644 males with ASTHMA_EOSINOPHIL_SUGG died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_EOSINOPHIL_SUGG.

N-year risk	Females	Males
1	0.075%	0.185%
5	0.543%	1.05%
10	1.386%	2.583%
15	2.677%	5.032%
20	4.728%	8.745%

Relationships between endpoints

↥

Index endpoint: ASTHMA_EOSINOPHIL_SUGG – Suggestive for eosinophilic asthma

GWS hits: 33

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Suggestive for eosinophilic asthma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints